{"gene":"BATF","run_date":"2026-06-09T22:02:44","timeline":{"discoveries":[{"year":1995,"finding":"B-ATF (BATF) is a nuclear bZIP protein that heterodimerizes with JUN family members (JunB, c-Jun, JunD) but not efficiently with c-Fos, and the B-ATF/c-Jun heterodimer binds AP-1 consensus DNA (TRE sites), establishing BATF as a tissue-specific modulator of AP-1 transcription.","method":"Yeast two-hybrid library screen, GST pulldown with in vitro translated proteins, EMSA","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple orthogonal in vitro binding assays (Y2H, GST pulldown, EMSA) in the founding paper; replicated in subsequent studies","pmids":["8570175"],"is_preprint":false},{"year":1996,"finding":"B-ATF physically associates with IFP 35, a leucine zipper protein translocated to the nucleus after interferon treatment, forming B-ATF:IFP 35 heterodimers as an interferon-inducible event.","method":"Co-immunoprecipitation, in vitro binding assay","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 3 / Weak — single lab, single co-IP/pulldown approach without functional mutagenesis","pmids":["8954125"],"is_preprint":false},{"year":1996,"finding":"SFA-2 (BATF) does not homodimerize efficiently but forms heterodimers preferentially with c-Jun; the SFA-2/c-Jun heterodimer binds preferentially to AP-1 (TRE) and CRE sites.","method":"In vitro dimerization assay, EMSA","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — in vitro biochemical assays, single lab, consistent with PMID 8570175","pmids":["8630063"],"is_preprint":false},{"year":2000,"finding":"B-ATF lacks a conventional transcriptional activation domain; Jun/B-ATF dimers bind TRE sites with a bias over CRE sites; B-ATF inhibits AP-1-mediated transcription in a dose-dependent manner by forming transcriptionally inert Jun/B-ATF heterodimers that compete with Fos for Jun; stable expression of B-ATF blocks focus formation by H-Ras and v-Fos oncoproteins.","method":"GAL4 chimeric reporter assay, EMSA, transient transfection reporter assay, focus-formation assay in C3H10T1/2 cells","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 1 / Moderate — multiple orthogonal functional assays (reporter, EMSA, transformation) in single lab establishing dominant-negative AP-1 mechanism","pmids":["10777209"],"is_preprint":false},{"year":2001,"finding":"Murine BATF/Jun heterodimers bind AP-1 consensus DNA and are transcriptionally inert; overexpression of BATF in thymic T cells reduces AP-1 transactivation in vivo, demonstrating BATF is a negative regulator of AP-1 activity in the thymus.","method":"In situ hybridization, AP-1 luciferase reporter transgenic mouse cross, transgenic overexpression","journal":"European journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo reporter assay in transgenic mice with functional readout, single lab","pmids":["11466704"],"is_preprint":false},{"year":2002,"finding":"BATF expression is induced as an early transcriptional response to IL-6/LIF stimulation and Stat3 activation in M1 myeloid leukemia cells; BATF forms complexes with c-Jun in these cells; forced BATF expression reduces cell growth rate.","method":"Representational difference analysis, immunoblot, co-immunoprecipitation, forced expression growth assay","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal co-IP plus functional growth assay, single lab","pmids":["12444555"],"is_preprint":false},{"year":2003,"finding":"BATF is phosphorylated in vivo on multiple serine and threonine residues and at least one tyrosine residue; phosphorylation of serine-43 within the DNA-binding domain (modeled by S43D mutation) converts BATF from a DNA-binding to a non-DNA-binding inhibitor of AP-1 activity while retaining dimerization with Jun and nuclear localization.","method":"In vivo phosphorylation labeling, reverse-polarity PAGE, site-directed mutagenesis (S43D), EMSA, nuclear localization assay, AP-1 reporter assay","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 1 / Moderate — reconstitution with mutagenesis plus multiple functional assays in single rigorous study","pmids":["12809553"],"is_preprint":false},{"year":2003,"finding":"EBNA2 and activated Notch up-regulate BATF expression in B cells within 24 h of EBV infection; BATF negatively impacts BZLF1 reporter expression and reduces the frequency of EBV lytic replication in latently infected cells.","method":"Differential gene expression analysis, reporter assay, viral replication frequency assay","journal":"Journal of virology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reporter assay and lytic replication functional readout, single lab","pmids":["12719594"],"is_preprint":false},{"year":2003,"finding":"Transgenic overexpression of BATF in T cells causes a severe deficiency of NKT cells, demonstrating that precise control of AP-1 activity mediated by BATF is critical for NKT cell development.","method":"Transgenic mouse model, flow cytometry, in vivo cytokine production assay","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — transgenic loss-of-function phenotype with defined cellular readout, single lab","pmids":["12594265"],"is_preprint":false},{"year":2009,"finding":"BATF is required for TH17 cell differentiation; Batf−/− T cells fail to induce RORγt and IL-21, are resistant to experimental autoimmune encephalomyelitis, and BATF binds conserved intergenic elements in the Il17a-Il17f locus and the Il17, Il21, and Il22 promoters after TH17 differentiation.","method":"Batf knockout mouse, ChIP, EMSA, retroviral overexpression, EAE model","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — KO mouse with defined phenotype, ChIP showing direct locus binding, replicated across multiple studies","pmids":["19578362"],"is_preprint":false},{"year":2010,"finding":"BATF is required for Th17, Th2, and Tfh cell differentiation and for B-cell class-switch recombination; adoptive transfer experiments established that the B-cell CSR defect is driven by T-cell intrinsic BATF loss, while B-cell-intrinsic BATF is also required for in vitro CSR.","method":"Batf knockout mouse (BatfΔZ/ΔZ), adoptive transfer, in vitro B-cell stimulation, Ig class-switch analysis","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple cellular assays plus adoptive transfer epistasis, replicated across labs","pmids":["20421391"],"is_preprint":false},{"year":2010,"finding":"PD-1 ligation upregulates BATF in exhausted CD8+ T cells; enforced BATF expression is sufficient to impair T cell proliferation and cytokine secretion; BATF knockdown reduces PD-1-mediated inhibition and rescues HIV-specific T cell function.","method":"Gene expression profiling of HIV-specific CD8+ T cells, lentiviral BATF overexpression, siRNA knockdown, T cell functional assays","journal":"Nature medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal gain- and loss-of-function with defined functional readouts in human and mouse systems","pmids":["20890291"],"is_preprint":false},{"year":2011,"finding":"BATF directly controls expression of Bcl-6 and c-Maf in T cells (required for Tfh development), and AID and germline IH-CH transcripts in B cells (required for CSR); coexpression of Bcl-6 and c-Maf restores Tfh activity in Batf−/− T cells.","method":"Batf knockout mouse, ChIP, in vivo complementation/rescue experiments, adoptive transfer","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — ChIP demonstrating direct binding plus genetic rescue experiments, multiple cell types","pmids":["21572431"],"is_preprint":false},{"year":2011,"finding":"BATF promotes effector CD8+ T-cell differentiation by inhibiting Sirt1 expression (together with c-Jun), resulting in increased histone acetylation of the T-bet locus and elevated cellular NAD+/ATP levels that support effector differentiation and survival.","method":"BATF-deficient mouse, ChIP for histone acetylation, NAD+/ATP measurement, transcriptional reporter assay","journal":"Proceedings of the National Academy of Sciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP plus metabolic assays, single lab, mechanistic pathway placement","pmids":["21873234"],"is_preprint":false},{"year":2011,"finding":"BATF induction downstream of Stat3 signaling in M1 myeloid leukemia cells is required for growth arrest and terminal macrophage differentiation; Stat3 binds the Batf promoter to drive its transcription; Batf in turn represses c-Myb to enable differentiation.","method":"RNA interference knockdown, rescue expression, ChIP for Stat3 at Batf promoter, gene expression analysis","journal":"Molecular cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP plus RNAi/rescue functional assays, single lab","pmids":["21296860"],"is_preprint":false},{"year":2012,"finding":"In CD4+ T cells, BATF-JUN complexes cooperate with IRF4 to bind AP1-IRF composite elements (AICEs; 5'-TGAnTCA/GAAA-3'); BATF binding is diminished in Irf4−/− T cells and IRF4 binding is diminished in Batf−/− T cells, demonstrating functional co-dependence; BATF-JUN-IRF4 complexes cooperatively promote Il10 transcription.","method":"ChIP-seq, EMSA, reporter assay, Irf4 and Batf KO T cells","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 / Strong — ChIP-seq plus EMSA plus reciprocal KO validation; independently replicated","pmids":["22992523"],"is_preprint":false},{"year":2012,"finding":"BATF (and BATF2) can compensate for BATF3 in CD8α+ dendritic cell development during infection; compensation is based on the shared capacity of BATF leucine zipper domains to interact with IRF4 and IRF8, mediating cooperative gene activation; reciprocal compensation between BATF and BATF3 also occurs in T cells for IL-10 and CTLA4 expression.","method":"Batf3 KO mouse, cytokine-driven rescue experiments, leucine zipper domain interaction studies, gene expression analysis","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis in vivo plus domain-based interaction mapping; independently replicated","pmids":["22992524"],"is_preprint":false},{"year":2013,"finding":"BATF is required for Th9 cell differentiation and IL-9 expression in both human and mouse T cells; BATF is enriched in Th9 cells and regulates a Th9-specific transcriptional network.","method":"Microarray, BATF KO mouse, BATF overexpression, allergic inflammation model","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 / Strong — KO and gain-of-function in both mouse and human, replicated in subsequent studies","pmids":["24216482"],"is_preprint":false},{"year":2013,"finding":"BATF is required for normal expression of gut-homing receptors CCR9 and α4β7 on T helper cells in response to retinoic acid; BATF-deficient T cells show defective RARα binding and histone acetylation at the regulatory regions of the CCR9 and Itg-α4 genes.","method":"BATF KO mouse, ChIP for RARα and histone acetylation, flow cytometry, intestinal T cell functional assays","journal":"The Journal of experimental medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP demonstrating direct epigenetic mechanism plus cellular phenotype, single lab","pmids":["23460729"],"is_preprint":false},{"year":2013,"finding":"Egr-2 interacts physically with BATF in CD4 T cells and suppresses its interaction with DNA sequences from the IL-17 promoter, thereby inhibiting Th17 differentiation; Egr-2 control of IL-17 is dependent on BATF inhibition without affecting STAT3 or RORγt.","method":"Co-immunoprecipitation, EMSA/DNA binding competition assay, Egr-2 KO mouse, Th17 differentiation assay","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP plus DNA binding assay plus KO phenotype, single lab","pmids":["23203924"],"is_preprint":false},{"year":2013,"finding":"EBNA3C binds strongest to BATF/IRF4 (AICE) and SPI1/IRF4 (EICE) composite sites genome-wide in LCLs; EBNA3C co-immunoprecipitates with Sin3A and is tethered to DNA through BATF-containing complexes; EBNA3C/Sin3A at promoters correlates with transcription downregulation including repression of p14ARF.","method":"ChIP-seq, co-immunoprecipitation, conditional EBNA3C inactivation","journal":"Proceedings of the National Academy of Sciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP-seq plus co-IP establishing BATF as tethering platform for EBNA3C, single study","pmids":["24344258"],"is_preprint":false},{"year":2014,"finding":"BATF is essential for early effector CD8+ T cell differentiation; BATF-deficient CD8+ T cells show proliferative and metabolic catastrophe early after antigen encounter; BATF together with IRF4 and Jun proteins binds regulatory regions and promotes early expression of T-bet and Blimp-1 while paradoxically repressing IFN-γ and granzyme B genes.","method":"Batf KO mouse, ChIP-seq, genome-wide transcriptional profiling, adoptive transfer","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — ChIP-seq plus KO with defined early and late phenotypic readouts; replicated across labs","pmids":["24584090"],"is_preprint":false},{"year":2014,"finding":"EBNA3A is tethered to DNA through BATF-containing protein complexes; ChIP-re-ChIP confirmed complexes of EBNA3A on DNA together with BATF; EBNA3A coincidence with BATF-IRF4 or RUNX3 is associated with stronger EBNA3A ChIP-seq signals.","method":"ChIP-seq, ChIP-re-ChIP","journal":"Proceedings of the National Academy of Sciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP-re-ChIP establishing protein complex on chromatin, single lab","pmids":["25540416"],"is_preprint":false},{"year":2014,"finding":"BATF is required for sustained CD8+ T cell effector function during LCMV infection; absence of BATF results in reduced CD8+ T cell responses and promotes viral persistence; IRF4 and BATF cooperate as necessary partners for antiviral cytotoxic T cell immunity.","method":"Irf4 KO and Batf KO mouse, LCMV infection model, T cell proliferation and effector function assays","journal":"Cell death and differentiation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — two independent KO lines with defined phenotypic readouts, single lab","pmids":["24531538"],"is_preprint":false},{"year":2014,"finding":"BATF is required to initiate but not maintain CD8+ T-cell effector differentiation; inducible in vivo RNAi showed BATF is essential for the initial commitment of naive CD8+ T cells to effector development but becomes dispensable by 72 h post-activation.","method":"Inducible in vivo RNAi (bone marrow chimera with inducible shRNA), flow cytometry, adoptive transfer","journal":"Proceedings of the National Academy of Sciences","confidence":"High","confidence_rationale":"Tier 2 / Moderate — novel in vivo inducible KD system with precise temporal resolution, single lab but strong mechanistic resolution","pmids":["25548173"],"is_preprint":false},{"year":2015,"finding":"IL-21 induces and sustains BATF expression in CD8+ T cells during chronic viral infection; BATF cooperates with IRF4 to preserve Blimp-1 expression and sustain CD8+ T cell effector function; BATF overexpression rescues 'unhelped' CD8+ T cells during chronic LCMV infection.","method":"Chronic LCMV infection model, conditional BATF KO, BATF overexpression, flow cytometry, gene expression","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — gain- and loss-of-function with defined molecular partner (IRF4) and target (Blimp-1), single lab","pmids":["26527008"],"is_preprint":false},{"year":2015,"finding":"BATF and IRF4 are necessary for VAT-Treg cell differentiation through direct regulation of ST2 and PPARγ expression.","method":"BATF and IRF4 conditional KO mice, ChIP, flow cytometry, metabolic phenotyping","journal":"Nature immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP plus KO phenotype establishing direct target regulation, single lab","pmids":["25599561"],"is_preprint":false},{"year":2015,"finding":"BATF, in cooperation with IRF4 along with STAT3 and STAT6, directly binds the CNS2 region of the IL-4 locus in Tfh cells to promote IL-4 expression; Batf-to-c-Maf signaling is an important determinant of IL-4 expression in Tfh cells.","method":"ChIP, reporter assay, BATF KO mouse, retroviral overexpression, allergic asthma model","journal":"Nature communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP at specific locus plus reporter assay, single lab","pmids":["26278622"],"is_preprint":false},{"year":2016,"finding":"Bach2 physically associates with BATF and binds regulatory regions of Th2 cytokine gene loci; the Bach2-BATF complex antagonizes recruitment of the BATF-IRF4 complex to AP-1 motifs, suppressing Th2 cytokine production; Bach2 also regulates Batf and Batf3 expression by inhibiting IL-4 production and by directly binding the Batf and Batf3 gene loci.","method":"Co-immunoprecipitation, ChIP, cytokine production assays, Bach2 KO mouse","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal co-IP plus ChIP establishing competitive complex formation, multiple orthogonal methods","pmids":["27581382"],"is_preprint":false},{"year":2016,"finding":"BATF/JUN-B and BATF/C-JUN complexes form in chondrocytes; overexpression of BATF induces upregulation of matrix-degrading enzymes and downregulation of cartilage matrix molecules; ChIP confirmed BATF and JUN binding to promoter regions of catabolic gene candidates; BATF knockout suppresses experimental osteoarthritis.","method":"ChIP, adenoviral BATF overexpression, BATF KO mouse, DMM and intra-articular injection OA models","journal":"Annals of the rheumatic diseases","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP plus KO and OE with defined phenotype, single lab","pmids":["27147707"],"is_preprint":false},{"year":2016,"finding":"In Th2 cells, BATF is enriched at the Rad50 hypersensitivity sites (RHS6 and RHS7) of the Th2 locus control region rather than at proximal cytokine promoters; BATF-deficient CD4+ T cells fail to acquire permissive epigenetic modifications at the Th2 locus linked to RHS6/7 function.","method":"ChIP-seq, BATF KO mouse, helminth infection model, epigenetic (H3K4me3/H3K27ac) profiling","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP-seq demonstrating novel LCR binding mechanism, single lab","pmids":["27798167"],"is_preprint":false},{"year":2017,"finding":"IRF1 and BATF are induced early by IL-27 during Tr1 cell differentiation and are required for differentiation and function; both transcription factors influence chromatin accessibility and expression of genes required for Tr1 cell function, with unique pioneering functions.","method":"ATAC-seq, ChIP-seq, IRF1 and BATF KO T cells, in vitro and in vivo Tr1 differentiation","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — ATAC-seq plus ChIP-seq plus KO phenotype establishing pioneering function; multiple orthogonal methods","pmids":["28166218"],"is_preprint":false},{"year":2017,"finding":"The BATF-IRF4 ternary complex shows a spectrum of occupancy at enhancers that correlates with sensitivity of gene expression to TCR signal strength; DNA sequences flanking the AICE motif control the affinity of BATF-IRF4 for direct binding to DNA; ChIP-exo identified a high-affinity AICE2 motif at a human CTLA-4-associated SNP.","method":"ChIP-seq, ChIP-exo, graded TCR stimulation, direct binding affinity measurements","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — ChIP-exo plus quantitative binding affinity analysis linking motif sequence to signal-strength-dependent gene expression","pmids":["28346410"],"is_preprint":false},{"year":2017,"finding":"A Foxp3 A384T missense mutation (IPEX patient-derived) impairs BATF expression in Treg cells by altering Foxp3-DNA binding specificity, broadening it at Batf target sites; repressed BATF expression contributes to tissue-restricted inflammation and impaired Treg competition in non-lymphoid tissues.","method":"Knock-in Foxp3 mutant mouse models, ChIP, Treg functional assays","journal":"Immunity","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP plus knock-in genetic model establishing Foxp3-BATF regulatory axis, single lab","pmids":["28778586"],"is_preprint":false},{"year":2018,"finding":"BATF, IRF4, and IRF8 are recruited to and bind AP1-IRF composite elements (AICEs) in the il12a, ebi3, and il10 loci in activated B cells (Bregs), driving IL-35 and IL-10 production.","method":"EMSA, ChIP assay on activated B cells","journal":"Journal of leukocyte biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — EMSA plus ChIP demonstrating direct locus binding, single lab","pmids":["30117603"],"is_preprint":false},{"year":2018,"finding":"BATF quantitative DNA binding preferences (as BATF-JUNB heterodimer and BATF-JUNB-IRF4/8 heterotrimer) were determined in vitro; without IRF, all three BATF family heterodimers show similar TRE/CRE preferences; IRF4/8 binding adjacent to BATF sites increases affinity substantially through protein-protein interactions and alters CRE vs TRE preference.","method":"Spec-seq (in vitro quantitative binding to large sequence collections), recombinant proteins","journal":"BMC molecular biology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution with quantitative binding measurements, systematic sequence analysis","pmids":["29587652"],"is_preprint":false},{"year":2018,"finding":"BATF controls formation of colon-infiltrating IL-7R+GM-CSF+ donor T effector memory cells that are sufficient to promote intestinal GVHD; this T cell subset's formation is dependent on T cell-intrinsic BATF expression.","method":"MHC-mismatched and miHA-mismatched GVHD mouse models, BATF KO adoptive transfer, flow cytometry","journal":"The Journal of clinical investigation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — cell-type-specific KO with defined cellular phenotype in two GVHD models, single lab","pmids":["29376889"],"is_preprint":false},{"year":2019,"finding":"Batf pioneers chromatin accessibility in developing effector T cells and controls developmentally regulated recruitment of the architectural factor Ctcf to promote chromatin looping associated with lineage-specific gene transcription; the Ctcf recruitment by Batf is largely dependent on Ets1 and does not require Batf-Irf complexes at AICE sites.","method":"ChIP-seq for Batf, Ctcf, and Ets1; ATAC-seq; Hi-C/chromatin interaction assays; Batf KO and Ets1 KO T cells","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — multiple genome-wide epigenomic methods plus KO establishing pioneer and architectural role, single lab","pmids":["31665634"],"is_preprint":false},{"year":2019,"finding":"BATF function in Th subsets is specified by its interacting partners: JunB and c-Jun (but not JunD) cooperate with BATF to promote IL-9 in Th9 cells; low Jun expression in Th17 cells limits BATF-driven IL-9; Bach2 cooperates with BATF to induce IL-9 by directly binding the Il9 gene.","method":"Primary mouse T cell culture, ectopic expression, ChIP, cytokine production assays","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP plus overexpression in primary T cells establishing partner-dependent specificity, single lab","pmids":["31451674"],"is_preprint":false},{"year":2020,"finding":"BATF is required for the molecular tissue program of nonlymphoid tissue Treg cell precursors residing in secondary lymphoid organs; global chromatin profiling showed BATF drives stepwise acquisition of chromatin accessibility toward the tissue Treg phenotype.","method":"scRNA-seq, ATAC-seq, BATF KO validation in precursor populations, Nfil3 reporter mice","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — ATAC-seq plus scRNA-seq plus functional KO validation; multiple orthogonal methods in single study","pmids":["31924477"],"is_preprint":false},{"year":2020,"finding":"STAT5 is the earliest factor binding and remodeling the Il9 locus in Th9 cells, and this is required for BATF binding at the Il9 locus; STAT5 mediates accessibility for BATF at the Il9 locus in multiple Th lineages, allowing acquisition of an IL-9-secreting phenotype; STAT5 and BATF together can convert Th17 cells to IL-9 producers.","method":"ChIP-seq, ATAC-seq, STAT5 and BATF KO T cells, retroviral overexpression, allergy and tumor models","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — ChIP-seq plus ATAC-seq plus KO establishing ordered pioneer mechanism, single lab with multiple orthogonal methods","pmids":["32985505"],"is_preprint":false},{"year":2020,"finding":"BATF is selectively required for the development and function of IL-25-responsive migratory iILC2s (IL-17RBhigh, KLRG1high) during helminth infection; BATF directly binds cis-regulatory elements of wound healing genes in ILC2s and maintains their chromatin accessibility; BATF also supports the IL-33-ST2 feed-forward loop sustaining ILC2 identity.","method":"BATF KO mouse, Nippostrongylus infection, scRNA-seq, ChIP-seq, flow cytometry","journal":"Science immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP-seq plus KO with defined cellular phenotype, single lab","pmids":["31924686"],"is_preprint":false},{"year":2020,"finding":"BATF is induced during ILC development at the α-lymphoid progenitor stage in response to IL-7; BATF binds and activates transcription of the Nfil3 gene to promote ILC hematopoiesis; BATF deficiency causes ILC lymphopenia affecting ILC1, ILC2, ILC3, and NK cells.","method":"BATF KO mouse, ChIP, IL-7 stimulation assays, bone marrow progenitor analysis, enteric infection model","journal":"Science immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP at Nfil3 locus plus KO phenotype, single lab","pmids":["33277375"],"is_preprint":false},{"year":2021,"finding":"BATF and IRF4 cooperate to counter T cell exhaustion in tumor-infiltrating CAR T cells; BATF overexpression in CAR T cells promotes survival, expansion, effector cytokine production, decreased TOX/inhibitory receptor expression, and generation of long-lived memory T cells; these responses require BATF-IRF4 protein-protein interaction, as a BATF variant unable to interact with IRF4 failed to mediate these effects.","method":"CAR T cell tumor models (mouse), BATF overexpression, BATF-IRF4 interaction-deficient BATF mutant, flow cytometry, tumor growth assays","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — domain mutagenesis establishing interaction requirement plus in vivo functional readout, multiple orthogonal assays","pmids":["34282330"],"is_preprint":false},{"year":2021,"finding":"BATF maintains a permissive chromatin structure allowing transition from TCF-1+ progenitor CD8+ T cells to CX3CR1+ cytotoxic effector cells during chronic viral infection; BATF directly binds regulatory regions near Tbx21 and Klf2 to modulate their enhancer accessibility.","method":"Genetic deletion of Batf in chronic LCMV model, ATAC-seq, ChIP-seq, gene regulatory network analysis","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — ATAC-seq plus ChIP-seq plus KO establishing direct chromatin mechanism, single lab with multiple orthogonal methods","pmids":["34282329"],"is_preprint":false},{"year":2021,"finding":"BATF promotes ILC2 proliferation and function and restricts ILC2-to-ILC3 plasticity during influenza infection; BATF directly binds cis-regulatory elements of wound healing genes and maintains their chromatin accessibility; BATF plays a role in an IL-33-ST2 feed-forward loop supporting ILC2 identity.","method":"BATF KO mouse, influenza infection model, scRNA-seq, ChIP-seq, ATAC-seq","journal":"Science immunology","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — ChIP-seq plus ATAC-seq plus KO with defined plasticity phenotype, single lab multiple orthogonal methods","pmids":["35030033"],"is_preprint":false},{"year":2021,"finding":"BATF directly binds and up-regulates a subset of exhaustion-related genes in human CAR T cells; knocking out BATF shifts the CAR T cell population toward a more central memory subset and enhances antitumor activity against solid tumors.","method":"Candidate gene screen, BATF KO (CRISPR) in human CAR T cells, ChIP, tumor xenograft models, transcriptomic analysis","journal":"Cancer cell","confidence":"High","confidence_rationale":"Tier 2 / Moderate — ChIP establishing direct binding plus CRISPR KO with in vivo functional readout, single lab","pmids":["36240777"],"is_preprint":false},{"year":2022,"finding":"BATF mediates chromatin organization at several levels in CD8+ T cells including regulatory region accessibility, enhancer-gene interactions, and TF co-binding; Batf and Irf4 together (not Batf alone) are sufficient to increase accessibility and transcription at key T cell function loci in fibroblasts; addition of Runx3 and T-bet further fine-tunes changes and is essential for establishing T cell-characteristic chromatin loops.","method":"ATAC-seq, ChIP-seq, Hi-C chromatin interaction mapping, ectopic TF overexpression in fibroblasts, Batf KO CD8+ T cells","journal":"Science immunology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — reconstitution in fibroblasts plus genome-wide epigenomic profiling establishing cooperative pioneer mechanism; multiple orthogonal methods","pmids":["35179948"],"is_preprint":false},{"year":2022,"finding":"BATF is a key regulator of Treg cell differentiation and activation in the tumor microenvironment, controlling activation-associated gene expression epigenetically; BATF deficiency in Treg cells inhibits tumor growth in mouse models.","method":"scRNA-seq, scATAC-seq, BATF KO in Treg cells (mouse), CUT&Tag, tumor growth assay","journal":"Science immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — scATAC plus KO phenotype in vivo, single lab","pmids":["36206353"],"is_preprint":false},{"year":2022,"finding":"BATF is required for maintenance of ILC3 lineage identity in the gut; BATF directly binds cis-regulatory elements of type 1 effector genes and restrains their chromatin accessibility; BATF also promotes chromatin accessibility of MHCII antigen presentation genes to facilitate transition to MHCII+ ILC3s.","method":"ILC3-specific BATF KO mouse, ATAC-seq, ChIP-seq, antibiotic treatment, IFN-γ blockade epistasis experiments","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — ATAC-seq plus ChIP-seq plus conditional KO with multiple mechanistic epistasis experiments, single lab","pmids":["36048018"],"is_preprint":false},{"year":2022,"finding":"FOSL1, FOSL2, and BATF share occupancy over regulatory regions of Th17 lineage commitment genes and share protein-interacting partners in human T cells; these AP-1 factors functionally interact during early human Th17 differentiation with BATF promoting the Th17 lineage.","method":"ChIP-seq, co-immunoprecipitation, siRNA knockdown in human T cells, genome-wide binding analysis","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP-seq plus co-IP in human primary cells, single lab","pmids":["35511484"],"is_preprint":false},{"year":2023,"finding":"Batf stabilizes Th17 cell identity by restraining IL-2 expression and IL-2-induced Stat5 activation, which in turn limits Stat5-dependent recruitment of Ets1-Runx1 factors to Th1- and Treg-specific gene loci; Batf thus acts indirectly to inhibit a competing Stat5-Ets1-Runx1 enhanceosome.","method":"Batf KO T cells, ChIP-seq for Stat5/Ets1/Runx1, IL-2 manipulation, Th17 stability assays","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Moderate — ChIP-seq plus genetic manipulation establishing indirect mechanism through competing enhanceosome, multiple orthogonal methods in single study","pmids":["36917143"],"is_preprint":false},{"year":2023,"finding":"BATF is a central component of a gene regulatory network governing TNFR+ intratumoral Treg cells; CRISPR-mediated BATF KO in human activated Tregs limits excessive activation and promotes survival of activated Tregs in vitro.","method":"scRNA-seq, CRISPR-Cas9 KO in human Tregs, bulk RNA-seq, immunophenotyping, in vitro functional suppression assay","journal":"Science immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — CRISPR KO plus transcriptomics in human primary cells, single lab","pmids":["37713508"],"is_preprint":false},{"year":2023,"finding":"BATF represses BIM (Bcl2l11) expression in anergic T cells to sustain peripheral tolerance; BATF-deficient tolerized CD4+ T cells resist anergy induction and undergo clonal deletion due to BIM upregulation; simultaneous Batf and Bcl2l11 double knockdown restores anergic T cell survival.","method":"In vivo antigen-driven anergy model, BATF KO and Bcl2l11 KO mouse, double-knockdown epistasis, ChIP/ATAC-seq","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — double-KD genetic epistasis plus epigenomic data establishing direct repression of BIM, single lab but rigorous experimental design","pmids":["37862030"],"is_preprint":false},{"year":2023,"finding":"BATF is required for Treg stability and FOXP3 expression; BATF regulates demethylation and chromatin accessibility of the CNS2 region of the Foxp3 locus; Treg-specific BATF KO causes multiorgan autoimmune pathology.","method":"Treg-specific BATF KO mouse, ATAC-seq, bisulfite sequencing (CNS2 methylation), ChIP-seq, flow cytometry","journal":"Advanced science","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — multiple epigenomic methods plus conditional KO with defined phenotype and locus-specific mechanism, single lab","pmids":["37587835"],"is_preprint":false},{"year":2023,"finding":"Tox-induced IL-10 expression in T cells is dependent on BATF; Tox and BATF co-bind regulatory regions of the IL-10 gene along with IRF4 and JunB; cosilencing of BATF abolishes Tox-mediated IL-10 induction but not PD-1 upregulation.","method":"ChIP, co-occupancy analysis, BATF siRNA knockdown, Tox overexpression in multiple Th subsets","journal":"Frontiers in immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP co-occupancy plus siRNA epistasis establishing BATF as downstream mediator, single lab","pmids":["38054003"],"is_preprint":false},{"year":2024,"finding":"METTL3 stabilizes BATF mRNA through m6A modification read by IGF2BP2, promoting BATF expression in inflammatory microglia; elevated BATF directly binds promoters of inflammatory cytokine and chemokine genes (including CXCL2) and drives TNF-dependent neurotoxicity; this METTL3-m6A-BATF axis promotes neuroinflammation after TBI.","method":"MeRIP-seq, CUT&Tag sequencing, METTL3 conditional KO in microglia, BATF ChIP, in vitro and in vivo TBI/stroke models","journal":"Cell death and differentiation","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — MeRIP-seq plus CUT&Tag plus conditional KO with mechanistic pathway (m6A-IGF2BP2-BATF) established; multiple orthogonal methods","pmids":["38902548"],"is_preprint":false},{"year":2024,"finding":"BATF is directly regulated by SMAD2/3 downstream of TGF-β/integrin signaling in NK cells; BATF in turn binds key NK cell exhaustion genes (HAVCR2, LAG3, TIGIT, CTLA4); BATF deletion enhances NK cell function against AML in vitro and in vivo.","method":"TGF-β/SMAD pathway inhibition, BATF KO in NK cells, ChIP-seq for BATF at exhaustion gene loci, in vitro and in vivo AML models","journal":"Science translational medicine","confidence":"High","confidence_rationale":"Tier 2 / Moderate — ChIP-seq plus KO with in vivo functional readout establishing upstream SMAD2/3 regulation and downstream binding targets, single lab multiple methods","pmids":["39259809"],"is_preprint":false},{"year":2024,"finding":"BATF directly binds the TGF-β1 promoter in AML cells, transcriptionally enhancing TGF-β1 expression and activating the TGF-β1/Smad2-3/MMP2/9 axis to promote AML cell migration and invasion.","method":"ChIP assay, luciferase reporter assay, siRNA knockdown and overexpression in AML cells, in vitro migration/invasion assays, in vivo AML model","journal":"Molecular carcinogenesis","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP plus reporter assay establishing direct promoter binding, functional KD/OE with defined pathway, single lab","pmids":["38477642"],"is_preprint":false},{"year":2021,"finding":"BATF directly binds the TGF-β1 promoter in breast cancer cells (confirmed by ChIP and dual luciferase reporter assay), increasing TGF-β1 mRNA and protein levels and promoting EMT; TGF-β1 knockdown reduces migration of BATF-overexpressing cells.","method":"Dual luciferase reporter assay, ChIP, siRNA knockdown, BATF overexpression in breast cancer cell lines","journal":"Aging","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP plus reporter assay confirming direct binding, functional epistasis, single lab","pmids":["34096887"],"is_preprint":false},{"year":2021,"finding":"BATF directly binds the GBP-5 promoter and transcriptionally activates GBP-5 expression, which promotes NLRP3 inflammasome activation and hepatocyte death in sepsis-associated liver injury.","method":"ChIP, luciferase reporter assay, BATF overexpression, NLRP3 inflammasome activation assay, LPS-induced SALI mouse model","journal":"FASEB journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP plus reporter assay establishing direct transcriptional activation, single lab","pmids":["34042221"],"is_preprint":false},{"year":2018,"finding":"BATF regulates B cell class-switch recombination by positively regulating Nfil3 and miR155hg, and negatively regulating Wnt10a; inducible BATF deletion demonstrated these are early regulatory targets upstream of germline transcript activation and Aicda induction.","method":"Inducible BATF deletion mouse model, ChIP, gene expression analysis, in vitro CSR assay","journal":"European journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP plus inducible KO establishing ordered regulatory network in B cells, single lab","pmids":["29898247"],"is_preprint":false}],"current_model":"BATF is a nuclear bZIP transcription factor that heterodimerizes with JUN family members to bind AP-1/TRE sites and lacks an intrinsic transactivation domain; it gains positive transcriptional activity by cooperating with IRF4 or IRF8 through BATF-JUN-IRF heterotrimer formation at AP1-IRF composite elements (AICEs), a partnership required for its essential roles as a pioneer/architectural factor that remodels chromatin and drives differentiation programs in TH17, TH2, TH9, Tfh, Tr1, Treg, effector and memory CD8+ T cells, ILC subsets, and B cells; phosphorylation of serine-43 in its DNA-binding domain converts BATF from a DNA-binding to a non-DNA-binding AP-1 inhibitor; upstream, BATF expression is induced by signals including STAT3 (via IL-6), IL-21, IL-7, TCR activation, PD-1, and SMAD2/3 (TGF-β), and is post-transcriptionally stabilized by METTL3-m6A-IGF2BP2; downstream, BATF directly binds cis-regulatory elements genome-wide, recruits Ctcf via Ets1 to organize chromatin loops, represses competing lineage programs (e.g., Stat5-Ets1-Runx1 in Th17 stability, BIM in anergic T cells), and transcriptionally activates target genes including Il17, Il21, Il22, Bcl6, c-Maf, AID, Nfil3, T-bet, Blimp-1, and TGF-β1 depending on cellular context."},"narrative":{"mechanistic_narrative":"BATF is a nuclear bZIP transcription factor that heterodimerizes with JUN family members (JunB, c-Jun, JunD) to bind AP-1/TRE elements and serves as a master architectural regulator of lymphocyte differentiation programs [PMID:8570175, PMID:19578362]. Because it lacks a conventional transactivation domain, BATF/JUN dimers are transcriptionally inert and originally function as dominant-negative competitors of Fos for Jun, inhibiting AP-1 activity in a dose-dependent manner [PMID:10777209, PMID:11466704]; phosphorylation of serine-43 within its DNA-binding domain further converts BATF into a non-DNA-binding AP-1 inhibitor while preserving dimerization and nuclear localization [PMID:12809553]. BATF gains positive, lineage-specifying transcriptional activity by cooperating with the interferon regulatory factors IRF4 and IRF8 to form BATF-JUN-IRF heterotrimers that bind AP1-IRF composite elements (AICEs); BATF and IRF4 are reciprocally co-dependent for genomic occupancy, and the sequence flanking the AICE motif tunes complex affinity and sensitivity to TCR signal strength [PMID:22992523, PMID:22992524, PMID:28346410, PMID:29587652]. Through this partnership BATF acts as a pioneer/architectural factor that opens chromatin, establishes lineage-specific enhancer accessibility, and—via Ets1-dependent recruitment of CTCF—organizes chromatin loops underlying effector gene transcription [PMID:28166218, PMID:31665634, PMID:35179948]. These activities make BATF essential for differentiation of TH17, TH2, TH9, Tfh, Tr1, and tissue/tumor Treg cells, effector and memory CD8+ T cells, ILC subsets, NK cells, and for B-cell class-switch recombination, where it directly activates programs including Il17/Il21/Il22, Bcl6 and c-Maf, T-bet and Blimp-1, AID and Nfil3 [PMID:19578362, PMID:20421391, PMID:21572431, PMID:24216482, PMID:24584090, PMID:33277375, PMID:36048018, PMID:29898247]. BATF also enforces regulatory and tolerance programs—stabilizing Th17 identity by restraining a competing Stat5-Ets1-Runx1 enhanceosome, sustaining anergic T cell survival by repressing BIM, and maintaining Foxp3/Treg stability via CNS2 demethylation—and is co-opted in T cell exhaustion downstream of PD-1, where its IRF4 partnership is required to either drive or, when deleted, relieve exhaustion in CAR T cells [PMID:20890291, PMID:34282330, PMID:36240777, PMID:36917143, PMID:37862030, PMID:37587835]. Upstream, BATF expression is induced by STAT3, IL-21, IL-7, TGF-β/SMAD2/3, and TCR/PD-1 signals and is post-transcriptionally stabilized by METTL3-m6A-IGF2BP2 [PMID:12444555, PMID:26527008, PMID:33277375, PMID:38902548, PMID:39259809].","teleology":[{"year":1995,"claim":"Established BATF's foundational biochemical identity, answering whether this bZIP protein acts alone or through dimerization to engage AP-1 DNA.","evidence":"Yeast two-hybrid, GST pulldown, and EMSA defining JUN-family heterodimerization and TRE binding","pmids":["8570175","8630063"],"confidence":"High","gaps":["No cellular function or target genes identified","Transcriptional output of the dimer not yet defined"]},{"year":2000,"claim":"Resolved whether BATF activates or represses AP-1 transcription, showing it lacks a transactivation domain and acts as a dominant-negative competitor for Jun.","evidence":"GAL4 reporter, EMSA, and focus-formation assays in fibroblasts","pmids":["10777209","11466704"],"confidence":"High","gaps":["Mechanism by which BATF later becomes a positive regulator unresolved","No physiological lineage context"]},{"year":2003,"claim":"Identified a post-translational switch—serine-43 phosphorylation—that toggles BATF between DNA-binding and non-DNA-binding inhibitory states.","evidence":"In vivo phospho-labeling and S43D mutagenesis with EMSA and AP-1 reporter assays","pmids":["12809553"],"confidence":"High","gaps":["Kinase responsible for S43 phosphorylation not identified","In vivo physiological role of the switch untested"]},{"year":2009,"claim":"Defined BATF's first essential developmental role, showing it is required for TH17 differentiation and binds the Il17/Il21/Il22 loci directly.","evidence":"Batf knockout mice, ChIP, EMSA, and EAE autoimmunity model","pmids":["19578362","20421391"],"confidence":"High","gaps":["How a transactivation-deficient factor activates target genes unexplained","Cofactors enabling positive output unknown"]},{"year":2011,"claim":"Extended BATF's reach to Tfh and B-cell programs and to CD8+ effector differentiation by identifying direct targets Bcl6, c-Maf, AID, and Sirt1-linked T-bet regulation.","evidence":"Knockout mice, ChIP, and genetic rescue/complementation experiments across T and B cells","pmids":["21572431","21873234","20890291"],"confidence":"High","gaps":["Molecular basis for positive transcription still missing","Direct vs indirect target distinction incomplete"]},{"year":2012,"claim":"Solved the central mechanistic puzzle of how a transactivation-deficient factor activates genes, showing BATF-JUN cooperates with IRF4 at AP1-IRF composite elements with reciprocal binding co-dependence.","evidence":"ChIP-seq, EMSA, reporter assays, and reciprocal Batf/Irf4 knockout T cells","pmids":["22992523","22992524"],"confidence":"High","gaps":["Structural basis of the heterotrimer not resolved","Determinants of context-specific target selection unknown"]},{"year":2013,"claim":"Broadened the lineage program (Th9, gut-homing receptors) and revealed antagonistic partners, showing Egr-2 binds BATF to block its DNA engagement and limit Th17.","evidence":"Knockout mice, ChIP for RARα and histone marks, co-IP, and DNA-binding competition assays","pmids":["24216482","23460729","23203924"],"confidence":"Medium","gaps":["Quantitative balance between activating and inhibitory partners undefined","Single-lab co-IP for Egr-2 interaction"]},{"year":2014,"claim":"Established BATF as essential specifically for initiation of CD8+ effector differentiation and antiviral cytotoxicity, with precise temporal resolution.","evidence":"ChIP-seq, Batf knockout, inducible in vivo RNAi, and LCMV infection models","pmids":["24584090","25548173","24531538"],"confidence":"High","gaps":["Mechanism for switch from required to dispensable not explained","Paradoxical repression of IFN-γ/granzyme B unresolved"]},{"year":2015,"claim":"Mapped BATF-IRF4 partnership into chronic infection and tissue Treg/Tfh programs, defining IL-21-driven induction and direct ST2/PPARγ/IL-4 locus regulation.","evidence":"Conditional knockouts, ChIP, reporter assays, and chronic LCMV/allergy models","pmids":["26527008","25599561","26278622"],"confidence":"Medium","gaps":["Single-lab studies for several lineage assignments","Quantitative contribution of each partner not separated"]},{"year":2016,"claim":"Revealed competitive and locus-control-region mechanisms, showing Bach2 antagonizes BATF-IRF4 recruitment at AP-1 motifs and BATF binds Th2 LCR hypersensitivity sites rather than proximal promoters.","evidence":"Reciprocal co-IP, ChIP/ChIP-seq, and Bach2/Batf knockout cytokine assays","pmids":["27581382","27798167","27147707"],"confidence":"High","gaps":["Stoichiometry of competing Bach2 vs IRF4 complexes undefined","How LCR binding propagates to promoters unresolved"]},{"year":2017,"claim":"Defined BATF as a pioneer factor controlling chromatin accessibility and showed AICE flanking sequence sets affinity and signal-strength sensitivity.","evidence":"ATAC-seq, ChIP-seq, ChIP-exo, graded TCR stimulation, and knockout Tr1 cells","pmids":["28166218","28346410","28778586"],"confidence":"High","gaps":["Direct demonstration of nucleosome engagement absent","Recruitment of remodeling machinery not identified"]},{"year":2018,"claim":"Quantified BATF dimer/trimer DNA preferences in vitro and extended its regulatory targets and B-cell network, showing IRF4/8 binding adjacent to BATF boosts affinity and shifts CRE/TRE preference.","evidence":"Spec-seq with recombinant proteins, EMSA/ChIP in Bregs, and inducible BATF deletion in B cells","pmids":["29587652","30117603","29898247"],"confidence":"High","gaps":["In vitro preferences not fully mapped to genomic occupancy","Mechanism of Wnt10a repression undefined"]},{"year":2019,"claim":"Established BATF's architectural role and partner-specified output, showing it recruits CTCF via Ets1 to organize chromatin loops independently of AICE sites.","evidence":"ChIP-seq for Batf/Ctcf/Ets1, ATAC-seq, Hi-C, and Batf/Ets1 knockout T cells; partner-swap overexpression","pmids":["31665634","31451674"],"confidence":"High","gaps":["Direct BATF-Ets1-CTCF biochemical contacts not mapped","Generality of loop organization across lineages untested"]},{"year":2020,"claim":"Defined an ordered pioneer hierarchy and expanded BATF to ILC biology, showing STAT5 remodels the Il9 locus to license BATF binding and BATF drives ILC hematopoiesis via Nfil3.","evidence":"ChIP-seq, ATAC-seq, scRNA-seq, and knockouts across Th9, tissue Treg, and ILC compartments","pmids":["32985505","31924477","33277375","31924686"],"confidence":"High","gaps":["Whether STAT5 directly hands off chromatin to BATF biochemically unknown","Cross-lineage generality of the ordered mechanism untested"]},{"year":2021,"claim":"Connected BATF to exhaustion/memory decisions and therapeutic engineering, showing its IRF4 partnership is required to counter CAR T exhaustion while BATF deletion can enhance memory and antitumor activity.","evidence":"CAR T tumor models, IRF4-interaction-deficient BATF mutant, CRISPR knockout, ATAC-seq/ChIP-seq in chronic LCMV and ILC2 models","pmids":["34282330","34282329","36240777","35030033"],"confidence":"High","gaps":["Context determining whether BATF promotes vs restrains exhaustion unresolved","Dose/timing dependence of therapeutic effect undefined"]},{"year":2022,"claim":"Demonstrated minimal-component sufficiency for chromatin remodeling and tumor Treg/ILC3 control, showing BATF+IRF4 (not BATF alone) open T-cell loci and BATF restrains type-1 effector genes in ILC3s.","evidence":"Reconstitution in fibroblasts, ATAC/ChIP-seq, Hi-C, conditional knockouts, and CUT&Tag","pmids":["35179948","36206353","36048018","35511484"],"confidence":"High","gaps":["Roles of additional factors (Runx3, T-bet) in establishing loops only partially defined","How BATF both opens and restrains accessibility at different loci unexplained"]},{"year":2023,"claim":"Resolved indirect and tolerance mechanisms, showing BATF stabilizes Th17 identity by restraining a competing Stat5-Ets1-Runx1 enhanceosome, sustains anergy by repressing BIM, and maintains Foxp3 stability via CNS2 demethylation.","evidence":"ChIP-seq, double-knockdown epistasis, bisulfite sequencing, and conditional knockouts with autoimmunity readouts","pmids":["36917143","37862030","37587835","37713508","38054003"],"confidence":"High","gaps":["Mechanism linking BATF to CNS2 demethylation machinery unresolved","How BATF achieves gene repression mechanistically incomplete"]},{"year":2024,"claim":"Defined upstream regulatory inputs and non-lymphoid roles, showing METTL3-m6A-IGF2BP2 stabilizes BATF mRNA in microglia and SMAD2/3 directly drives BATF in NK cells to control exhaustion gene loci.","evidence":"MeRIP-seq, CUT&Tag, conditional METTL3 knockout, ChIP-seq, and AML/TBI in vivo models","pmids":["38902548","39259809","38477642"],"confidence":"High","gaps":["Integration of m6A and SMAD inputs with transcriptional induction unresolved","Generality of microglial/NK roles beyond disease models untested"]},{"year":null,"claim":"How a single architectural factor switches between opening lineage-specific chromatin and restraining alternative-fate loci, and what dictates its context-dependent activating versus repressive output, remains unresolved.","evidence":"","pmids":[],"confidence":"High","gaps":["No high-resolution structure of the BATF-JUN-IRF trimer on nucleosomal DNA","Chromatin-remodeling machinery recruited by BATF not identified","Rules selecting activation vs repression at a given locus undefined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,3,9,15,21]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[0,2,9,15,32,35]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[37,20,22]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,6]},{"term_id":"GO:0000228","term_label":"nuclear chromosome","supporting_discovery_ids":[9,15,37]}],"pathway":[{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[9,10,11,21,43]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[3,9,15,12]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[31,37,47,54]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[10,17,42,39]}],"complexes":["BATF-JUN AP-1 heterodimer","BATF-JUN-IRF4 (AICE) ternary complex","BATF-JUN-IRF8 (AICE) complex"],"partners":["JUN","JUNB","IRF4","IRF8","CTCF","ETS1","BACH2","EGR2"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q16520","full_name":"Basic leucine zipper transcriptional factor ATF-like","aliases":["B-cell-activating transcription factor","B-ATF","SF-HT-activated gene 2 protein","SFA-2"],"length_aa":125,"mass_kda":14.1,"function":"AP-1 family transcription factor that controls the differentiation of lineage-specific cells in the immune system: specifically mediates the differentiation of T-helper 17 cells (Th17), follicular T-helper cells (TfH), CD8(+) dendritic cells and class-switch recombination (CSR) in B-cells. Acts via the formation of a heterodimer with JUNB that recognizes and binds DNA sequence 5'-TGA[CG]TCA-3'. The BATF-JUNB heterodimer also forms a complex with IRF4 (or IRF8) in immune cells, leading to recognition of AICE sequence (5'-TGAnTCA/GAAA-3'), an immune-specific regulatory element, followed by cooperative binding of BATF and IRF4 (or IRF8) and activation of genes. Controls differentiation of T-helper cells producing interleukin-17 (Th17 cells) by binding to Th17-associated gene promoters: regulates expression of the transcription factor RORC itself and RORC target genes such as IL17 (IL17A or IL17B). Also involved in differentiation of follicular T-helper cells (TfH) by directing expression of BCL6 and MAF. In B-cells, involved in class-switch recombination (CSR) by controlling the expression of both AICDA and of germline transcripts of the intervening heavy-chain region and constant heavy-chain region (I(H)-C(H)). Following infection, can participate in CD8(+) dendritic cell differentiation via interaction with IRF4 and IRF8 to mediate cooperative gene activation. Regulates effector CD8(+) T-cell differentiation by regulating expression of SIRT1. Following DNA damage, part of a differentiation checkpoint that limits self-renewal of hematopoietic stem cells (HSCs): up-regulated by STAT3, leading to differentiation of HSCs, thereby restricting self-renewal of HSCs (By similarity)","subcellular_location":"Nucleus; Cytoplasm","url":"https://www.uniprot.org/uniprotkb/Q16520/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/BATF","classification":"Not Classified","n_dependent_lines":12,"n_total_lines":1208,"dependency_fraction":0.009933774834437087},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/BATF","total_profiled":1310},"omim":[{"mim_id":"614983","title":"BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR, ATF-LIKE 2; BATF2","url":"https://www.omim.org/entry/614983"},{"mim_id":"612476","title":"BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR, ATF-LIKE; BATF","url":"https://www.omim.org/entry/612476"},{"mim_id":"612470","title":"BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR, ATF-LIKE 3; BATF3","url":"https://www.omim.org/entry/612470"},{"mim_id":"610562","title":"ZINC FINGER CCCH DOMAIN-CONTAINING PROTEIN 12A; ZC3H12A","url":"https://www.omim.org/entry/610562"},{"mim_id":"603149","title":"INTERLEUKIN 17A; IL17A","url":"https://www.omim.org/entry/603149"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Nucleoplasm","reliability":"Enhanced"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"bone marrow","ntpm":20.5},{"tissue":"lymphoid tissue","ntpm":28.7}],"url":"https://www.proteinatlas.org/search/BATF"},"hgnc":{"alias_symbol":["B-ATF","SFA-2","BATF1"],"prev_symbol":[]},"alphafold":{"accession":"Q16520","domains":[{"cath_id":"1.20.5","chopping":"24-89","consensus_level":"high","plddt":97.6302,"start":24,"end":89}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q16520","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q16520-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q16520-F1-predicted_aligned_error_v6.png","plddt_mean":80.69},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=BATF","jax_strain_url":"https://www.jax.org/strain/search?query=BATF"},"sequence":{"accession":"Q16520","fasta_url":"https://rest.uniprot.org/uniprotkb/Q16520.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q16520/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q16520"}},"corpus_meta":[{"pmid":"19578362","id":"PMC_19578362","title":"The AP-1 transcription factor Batf controls T(H)17 differentiation.","date":"2009","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/19578362","citation_count":498,"is_preprint":false},{"pmid":"25599561","id":"PMC_25599561","title":"The transcriptional regulators IRF4, BATF and IL-33 orchestrate development and maintenance of adipose tissue-resident regulatory T cells.","date":"2015","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/25599561","citation_count":469,"is_preprint":false},{"pmid":"20890291","id":"PMC_20890291","title":"Transcriptional analysis of HIV-specific CD8+ T cells shows that PD-1 inhibits T cell function by upregulating BATF.","date":"2010","source":"Nature medicine","url":"https://pubmed.ncbi.nlm.nih.gov/20890291","citation_count":433,"is_preprint":false},{"pmid":"22992523","id":"PMC_22992523","title":"BATF-JUN is critical for IRF4-mediated transcription in T cells.","date":"2012","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/22992523","citation_count":372,"is_preprint":false},{"pmid":"22992524","id":"PMC_22992524","title":"Compensatory dendritic cell development mediated by BATF-IRF interactions.","date":"2012","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/22992524","citation_count":341,"is_preprint":false},{"pmid":"24584090","id":"PMC_24584090","title":"The transcription factor BATF operates as an essential differentiation checkpoint in early effector CD8+ T cells.","date":"2014","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/24584090","citation_count":316,"is_preprint":false},{"pmid":"23787991","id":"PMC_23787991","title":"Specificity through cooperation: BATF-IRF interactions control immune-regulatory networks.","date":"2013","source":"Nature reviews. Immunology","url":"https://pubmed.ncbi.nlm.nih.gov/23787991","citation_count":315,"is_preprint":false},{"pmid":"21572431","id":"PMC_21572431","title":"The transcription factor BATF controls the global regulators of class-switch recombination in both B cells and T cells.","date":"2011","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/21572431","citation_count":315,"is_preprint":false},{"pmid":"34282330","id":"PMC_34282330","title":"BATF and IRF4 cooperate to counter exhaustion in tumor-infiltrating CAR T cells.","date":"2021","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/34282330","citation_count":298,"is_preprint":false},{"pmid":"20421391","id":"PMC_20421391","title":"Batf coordinates multiple aspects of B and T cell function required for normal antibody responses.","date":"2010","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/20421391","citation_count":203,"is_preprint":false},{"pmid":"31924477","id":"PMC_31924477","title":"Precursors for Nonlymphoid-Tissue Treg Cells Reside in Secondary Lymphoid Organs and Are Programmed by the Transcription Factor BATF.","date":"2020","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/31924477","citation_count":201,"is_preprint":false},{"pmid":"24216482","id":"PMC_24216482","title":"Th9 cell development requires a BATF-regulated transcriptional network.","date":"2013","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/24216482","citation_count":193,"is_preprint":false},{"pmid":"34282329","id":"PMC_34282329","title":"BATF regulates progenitor to cytolytic effector CD8+ T cell transition during chronic viral infection.","date":"2021","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/34282329","citation_count":158,"is_preprint":false},{"pmid":"36240777","id":"PMC_36240777","title":"Depletion of BATF in CAR-T cells enhances antitumor activity by inducing resistance against exhaustion and formation of central memory cells.","date":"2022","source":"Cancer cell","url":"https://pubmed.ncbi.nlm.nih.gov/36240777","citation_count":139,"is_preprint":false},{"pmid":"28778586","id":"PMC_28778586","title":"Analyses of a Mutant Foxp3 Allele Reveal BATF as a Critical Transcription Factor in the Differentiation and Accumulation of Tissue Regulatory T Cells.","date":"2017","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/28778586","citation_count":131,"is_preprint":false},{"pmid":"26527008","id":"PMC_26527008","title":"A Critical Role of IL-21-Induced BATF in Sustaining CD8-T-Cell-Mediated Chronic Viral Control.","date":"2015","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/26527008","citation_count":121,"is_preprint":false},{"pmid":"8570175","id":"PMC_8570175","title":"B-ATF: a novel human bZIP protein that associates with members of the AP-1 transcription factor family.","date":"1995","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/8570175","citation_count":110,"is_preprint":false},{"pmid":"28346410","id":"PMC_28346410","title":"Quality of TCR signaling determined by differential affinities of enhancers for the composite BATF-IRF4 transcription factor complex.","date":"2017","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/28346410","citation_count":107,"is_preprint":false},{"pmid":"21873234","id":"PMC_21873234","title":"Basic leucine zipper transcription factor, ATF-like (BATF) regulates epigenetically and energetically effector CD8 T-cell differentiation via Sirt1 expression.","date":"2011","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/21873234","citation_count":100,"is_preprint":false},{"pmid":"26278622","id":"PMC_26278622","title":"Batf is important for IL-4 expression in T follicular helper cells.","date":"2015","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/26278622","citation_count":99,"is_preprint":false},{"pmid":"28166218","id":"PMC_28166218","title":"Critical role of IRF1 and BATF in forming chromatin landscape during type 1 regulatory cell differentiation.","date":"2017","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/28166218","citation_count":96,"is_preprint":false},{"pmid":"10777209","id":"PMC_10777209","title":"B-ATF functions as a negative regulator of AP-1 mediated transcription and blocks cellular transformation by Ras and Fos.","date":"2000","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/10777209","citation_count":96,"is_preprint":false},{"pmid":"36206353","id":"PMC_36206353","title":"BATF epigenetically and transcriptionally controls the activation program of regulatory T cells in human tumors.","date":"2022","source":"Science immunology","url":"https://pubmed.ncbi.nlm.nih.gov/36206353","citation_count":91,"is_preprint":false},{"pmid":"31665634","id":"PMC_31665634","title":"Batf Pioneers the Reorganization of Chromatin in Developing Effector T Cells via Ets1-Dependent Recruitment of Ctcf.","date":"2019","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/31665634","citation_count":85,"is_preprint":false},{"pmid":"24344258","id":"PMC_24344258","title":"Epstein-Barr virus nuclear antigen 3C binds to BATF/IRF4 or SPI1/IRF4 composite sites and recruits Sin3A to repress CDKN2A.","date":"2013","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/24344258","citation_count":84,"is_preprint":false},{"pmid":"27581382","id":"PMC_27581382","title":"Bach2-Batf interactions control Th2-type immune response by regulating the IL-4 amplification loop.","date":"2016","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/27581382","citation_count":82,"is_preprint":false},{"pmid":"29588546","id":"PMC_29588546","title":"The AP-1-BATF and -BATF3 module is essential for growth, survival and TH17/ILC3 skewing of anaplastic large cell lymphoma.","date":"2018","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/29588546","citation_count":76,"is_preprint":false},{"pmid":"31924686","id":"PMC_31924686","title":"BATF acts as an essential regulator of IL-25-responsive migratory ILC2 cell fate and function.","date":"2020","source":"Science immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31924686","citation_count":72,"is_preprint":false},{"pmid":"24531538","id":"PMC_24531538","title":"IRF4 and BATF are critical for CD8⁺ T-cell function following infection with LCMV.","date":"2014","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/24531538","citation_count":69,"is_preprint":false},{"pmid":"25838550","id":"PMC_25838550","title":"Batf-dependent Th17 cells critically regulate IL-23 driven colitis-associated colon cancer.","date":"2015","source":"Gut","url":"https://pubmed.ncbi.nlm.nih.gov/25838550","citation_count":68,"is_preprint":false},{"pmid":"29984361","id":"PMC_29984361","title":"The expansion in lymphoid organs of IL-4+ BATF+ T follicular helper cells is linked to IgG4 class switching in vivo.","date":"2018","source":"Life science alliance","url":"https://pubmed.ncbi.nlm.nih.gov/29984361","citation_count":66,"is_preprint":false},{"pmid":"11466704","id":"PMC_11466704","title":"Characterization of murine BATF: a negative regulator of activator protein-1 activity in the thymus.","date":"2001","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/11466704","citation_count":63,"is_preprint":false},{"pmid":"27147707","id":"PMC_27147707","title":"Inhibition of BATF/JUN transcriptional activity protects against osteoarthritic cartilage destruction.","date":"2016","source":"Annals of the rheumatic diseases","url":"https://pubmed.ncbi.nlm.nih.gov/27147707","citation_count":58,"is_preprint":false},{"pmid":"23460729","id":"PMC_23460729","title":"BATF is required for normal expression of gut-homing receptors by T helper cells in response to retinoic acid.","date":"2013","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/23460729","citation_count":52,"is_preprint":false},{"pmid":"23203924","id":"PMC_23203924","title":"Early growth response gene-2 controls IL-17 expression and Th17 differentiation by negatively regulating Batf.","date":"2012","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/23203924","citation_count":50,"is_preprint":false},{"pmid":"38902548","id":"PMC_38902548","title":"The m6A methyltransferase METTL3 drives neuroinflammation and neurotoxicity through stabilizing BATF mRNA in microglia.","date":"2024","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/38902548","citation_count":48,"is_preprint":false},{"pmid":"35179948","id":"PMC_35179948","title":"Batf-mediated epigenetic control of effector CD8+ T cell differentiation.","date":"2022","source":"Science immunology","url":"https://pubmed.ncbi.nlm.nih.gov/35179948","citation_count":48,"is_preprint":false},{"pmid":"34096887","id":"PMC_34096887","title":"Calycosin inhibits breast cancer cell migration and invasion by suppressing EMT via BATF/TGF-β1.","date":"2021","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/34096887","citation_count":48,"is_preprint":false},{"pmid":"25540416","id":"PMC_25540416","title":"Epstein-Barr virus nuclear antigen 3A partially coincides with EBNA3C genome-wide and is tethered to DNA through BATF complexes.","date":"2014","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/25540416","citation_count":48,"is_preprint":false},{"pmid":"24290279","id":"PMC_24290279","title":"The activating protein 1 transcription factor basic leucine zipper transcription factor, ATF-like (BATF), regulates lymphocyte- and mast cell-driven immune responses in the setting of allergic asthma.","date":"2013","source":"The Journal of allergy and clinical immunology","url":"https://pubmed.ncbi.nlm.nih.gov/24290279","citation_count":45,"is_preprint":false},{"pmid":"24875472","id":"PMC_24875472","title":"SPIB and BATF provide alternate determinants of IRF4 occupancy in diffuse large B-cell lymphoma linked to disease heterogeneity.","date":"2014","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/24875472","citation_count":44,"is_preprint":false},{"pmid":"30288360","id":"PMC_30288360","title":"IL-6 augments IL-4-induced polarization of primary human macrophages through synergy of STAT3, STAT6 and BATF transcription factors.","date":"2018","source":"Oncoimmunology","url":"https://pubmed.ncbi.nlm.nih.gov/30288360","citation_count":44,"is_preprint":false},{"pmid":"32985505","id":"PMC_32985505","title":"STAT5 promotes accessibility and is required for BATF-mediated plasticity at the Il9 locus.","date":"2020","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/32985505","citation_count":40,"is_preprint":false},{"pmid":"30117603","id":"PMC_30117603","title":"Production of IL-35 by Bregs is mediated through binding of BATF-IRF-4-IRF-8 complex to il12a and ebi3 promoter elements.","date":"2018","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/30117603","citation_count":40,"is_preprint":false},{"pmid":"12719594","id":"PMC_12719594","title":"EBNA2 and activated Notch induce expression of BATF.","date":"2003","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/12719594","citation_count":39,"is_preprint":false},{"pmid":"27798167","id":"PMC_27798167","title":"BATF Modulates the Th2 Locus Control Region and Regulates CD4+ T Cell Fate during Antihelminth Immunity.","date":"2016","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/27798167","citation_count":38,"is_preprint":false},{"pmid":"12594265","id":"PMC_12594265","title":"BATF transgenic mice reveal a role for activator protein-1 in NKT cell development.","date":"2003","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/12594265","citation_count":37,"is_preprint":false},{"pmid":"35030033","id":"PMC_35030033","title":"BATF promotes group 2 innate lymphoid cell-mediated lung tissue protection during acute respiratory virus infection.","date":"2022","source":"Science immunology","url":"https://pubmed.ncbi.nlm.nih.gov/35030033","citation_count":36,"is_preprint":false},{"pmid":"12809553","id":"PMC_12809553","title":"Phosphorylation of BATF regulates DNA binding: a novel mechanism for AP-1 (activator protein-1) regulation.","date":"2003","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/12809553","citation_count":36,"is_preprint":false},{"pmid":"29376889","id":"PMC_29376889","title":"BATF-dependent IL-7RhiGM-CSF+ T cells control intestinal graft-versus-host disease.","date":"2018","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/29376889","citation_count":36,"is_preprint":false},{"pmid":"25548173","id":"PMC_25548173","title":"Inducible RNAi in vivo reveals that the transcription factor BATF is required to initiate but not maintain CD8+ T-cell effector differentiation.","date":"2014","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/25548173","citation_count":32,"is_preprint":false},{"pmid":"33809259","id":"PMC_33809259","title":"Harnessing the IL-21-BATF Pathway in the CD8+ T Cell Anti-Tumor Response.","date":"2021","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/33809259","citation_count":31,"is_preprint":false},{"pmid":"35511484","id":"PMC_35511484","title":"A systematic comparison of FOSL1, FOSL2 and BATF-mediated transcriptional regulation during early human Th17 differentiation.","date":"2022","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/35511484","citation_count":30,"is_preprint":false},{"pmid":"12444555","id":"PMC_12444555","title":"Stat3-dependent induction of BATF in M1 mouse myeloid leukemia cells.","date":"2002","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/12444555","citation_count":30,"is_preprint":false},{"pmid":"33069715","id":"PMC_33069715","title":"IL-4-BATF signaling directly modulates IL-9 producing mucosal mast cell (MMC9) function in experimental food allergy.","date":"2020","source":"The Journal of allergy and clinical immunology","url":"https://pubmed.ncbi.nlm.nih.gov/33069715","citation_count":30,"is_preprint":false},{"pmid":"36917143","id":"PMC_36917143","title":"Batf stabilizes Th17 cell development via impaired Stat5 recruitment of Ets1-Runx1 complexes.","date":"2023","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/36917143","citation_count":29,"is_preprint":false},{"pmid":"21296860","id":"PMC_21296860","title":"Batf promotes growth arrest and terminal differentiation of mouse myeloid leukemia cells.","date":"2011","source":"Molecular cancer research : MCR","url":"https://pubmed.ncbi.nlm.nih.gov/21296860","citation_count":29,"is_preprint":false},{"pmid":"26970726","id":"PMC_26970726","title":"The transcription factor BATF modulates cytokine-mediated responses in T cells.","date":"2016","source":"Cytokine & growth factor reviews","url":"https://pubmed.ncbi.nlm.nih.gov/26970726","citation_count":28,"is_preprint":false},{"pmid":"33277375","id":"PMC_33277375","title":"BATF regulates innate lymphoid cell hematopoiesis and homeostasis.","date":"2020","source":"Science immunology","url":"https://pubmed.ncbi.nlm.nih.gov/33277375","citation_count":27,"is_preprint":false},{"pmid":"37713508","id":"PMC_37713508","title":"Integrated BATF transcriptional network regulates suppressive intratumoral regulatory T cells.","date":"2023","source":"Science immunology","url":"https://pubmed.ncbi.nlm.nih.gov/37713508","citation_count":27,"is_preprint":false},{"pmid":"8954125","id":"PMC_8954125","title":"IFP 35 forms complexes with B-ATF, a member of the AP1 family of transcription factors.","date":"1996","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/8954125","citation_count":27,"is_preprint":false},{"pmid":"33879580","id":"PMC_33879580","title":"BATF Regulates T Regulatory Cell Functional Specification and Fitness of Triglyceride Metabolism in Restraining Allergic Responses.","date":"2021","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/33879580","citation_count":26,"is_preprint":false},{"pmid":"17182540","id":"PMC_17182540","title":"Sensitivity of NK1.1-negative NKT cells to transgenic BATF defines a role for activator protein-1 in the expansion and maturation of immature NKT cells in the thymus.","date":"2007","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/17182540","citation_count":26,"is_preprint":false},{"pmid":"31897131","id":"PMC_31897131","title":"BATF acts as an oncogene in non-small cell lung cancer.","date":"2019","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/31897131","citation_count":25,"is_preprint":false},{"pmid":"39259809","id":"PMC_39259809","title":"BATF is a major driver of NK cell epigenetic reprogramming and dysfunction in AML.","date":"2024","source":"Science translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/39259809","citation_count":24,"is_preprint":false},{"pmid":"15913695","id":"PMC_15913695","title":"Tumor model-specific proviral insertional mutagenesis of the Fos/Jdp2/Batf locus.","date":"2005","source":"Virology","url":"https://pubmed.ncbi.nlm.nih.gov/15913695","citation_count":24,"is_preprint":false},{"pmid":"36048018","id":"PMC_36048018","title":"Group 3 innate lymphoid cells require BATF to regulate gut homeostasis in mice.","date":"2022","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/36048018","citation_count":21,"is_preprint":false},{"pmid":"39876010","id":"PMC_39876010","title":"The role of BATF in immune cell differentiation and autoimmune diseases.","date":"2025","source":"Biomarker research","url":"https://pubmed.ncbi.nlm.nih.gov/39876010","citation_count":19,"is_preprint":false},{"pmid":"23537103","id":"PMC_23537103","title":"BATF regulates the development and function of IL-17 producing iNKT cells.","date":"2013","source":"BMC immunology","url":"https://pubmed.ncbi.nlm.nih.gov/23537103","citation_count":19,"is_preprint":false},{"pmid":"19726487","id":"PMC_19726487","title":"BATF: bringing (in) another Th17-regulating factor.","date":"2009","source":"Journal of molecular cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/19726487","citation_count":19,"is_preprint":false},{"pmid":"37587835","id":"PMC_37587835","title":"BATF is Required for Treg Homeostasis and Stability to Prevent Autoimmune Pathology.","date":"2023","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/37587835","citation_count":18,"is_preprint":false},{"pmid":"34282328","id":"PMC_34282328","title":"BATF targets T cell exhaustion for termination.","date":"2021","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/34282328","citation_count":18,"is_preprint":false},{"pmid":"34042221","id":"PMC_34042221","title":"Transcriptional enhancement of GBP-5 by BATF aggravates sepsis-associated liver injury via NLRP3 inflammasome activation.","date":"2021","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/34042221","citation_count":18,"is_preprint":false},{"pmid":"8630063","id":"PMC_8630063","title":"SFA-2, a novel bZIP transcription factor induced by human T-cell leukemia virus type I, is highly expressed in mature lymphocytes.","date":"1996","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/8630063","citation_count":18,"is_preprint":false},{"pmid":"30071881","id":"PMC_30071881","title":"BATF regulates collagen-induced arthritis by regulating T helper cell differentiation.","date":"2018","source":"Arthritis research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/30071881","citation_count":17,"is_preprint":false},{"pmid":"29587652","id":"PMC_29587652","title":"Quantitative profiling of BATF family proteins/JUNB/IRF hetero-trimers using Spec-seq.","date":"2018","source":"BMC molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/29587652","citation_count":17,"is_preprint":false},{"pmid":"31776325","id":"PMC_31776325","title":"BATF3 is sufficient for the induction of Il9 expression and can compensate for BATF during Th9 cell differentiation.","date":"2019","source":"Experimental & molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31776325","citation_count":16,"is_preprint":false},{"pmid":"25491772","id":"PMC_25491772","title":"Increased expression of the Th17-IL-6R/pSTAT3/BATF/RorγT-axis in the tumoural region of adenocarcinoma as compared to squamous cell carcinoma of the lung.","date":"2014","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/25491772","citation_count":16,"is_preprint":false},{"pmid":"37862030","id":"PMC_37862030","title":"BATF represses BIM to sustain tolerant T cells in the periphery.","date":"2023","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/37862030","citation_count":15,"is_preprint":false},{"pmid":"34599765","id":"PMC_34599765","title":"Genetically targeting the BATF family transcription factors BATF and BATF3 in the mouse abrogates effector T cell activities and enables long-term heart allograft survival.","date":"2021","source":"American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons","url":"https://pubmed.ncbi.nlm.nih.gov/34599765","citation_count":15,"is_preprint":false},{"pmid":"23628948","id":"PMC_23628948","title":"IL-6 activated integrated BATF/IRF4 functions in lymphocytes are T-bet-independent and reversed by subcutaneous immunotherapy.","date":"2013","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/23628948","citation_count":15,"is_preprint":false},{"pmid":"36982699","id":"PMC_36982699","title":"Transcriptome Analysis of Diffuse Large B-Cell Lymphoma Cells Inducibly Expressing MyD88 L265P Mutation Identifies Upregulated CD44, LGALS3, NFKBIZ, and BATF as Downstream Targets of Oncogenic NF-κB Signaling.","date":"2023","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/36982699","citation_count":14,"is_preprint":false},{"pmid":"27548324","id":"PMC_27548324","title":"Immunopathogenesis of IBD: Batf as a Key Driver of Disease Activity.","date":"2016","source":"Digestive diseases (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/27548324","citation_count":14,"is_preprint":false},{"pmid":"31451674","id":"PMC_31451674","title":"BATF-Interacting Proteins Dictate Specificity in Th Subset Activity.","date":"2019","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/31451674","citation_count":13,"is_preprint":false},{"pmid":"38833676","id":"PMC_38833676","title":"BATF-dependent Th17 cells act through the IL-23R pathway to promote prostate adenocarcinoma initiation and progression.","date":"2024","source":"Journal of the National Cancer Institute","url":"https://pubmed.ncbi.nlm.nih.gov/38833676","citation_count":12,"is_preprint":false},{"pmid":"26557810","id":"PMC_26557810","title":"Engagement of CD99 Reduces AP-1 Activity by Inducing BATF in the Human Multiple Myeloma Cell Line RPMI8226.","date":"2015","source":"Immune network","url":"https://pubmed.ncbi.nlm.nih.gov/26557810","citation_count":12,"is_preprint":false},{"pmid":"22592317","id":"PMC_22592317","title":"Overexpression of Batf induces an apoptotic defect and an associated lymphoproliferative disorder in mice.","date":"2012","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/22592317","citation_count":12,"is_preprint":false},{"pmid":"38054003","id":"PMC_38054003","title":"Tox induces T cell IL-10 production in a BATF-dependent manner.","date":"2023","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/38054003","citation_count":11,"is_preprint":false},{"pmid":"31681314","id":"PMC_31681314","title":"BATF Potentially Mediates Negative Regulation of PD-1/PD-Ls Pathway on T Cell Functions in Mycobacterium tuberculosis Infection.","date":"2019","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31681314","citation_count":11,"is_preprint":false},{"pmid":"39407311","id":"PMC_39407311","title":"BRD4 inhibitor reduces exhaustion and blocks terminal differentiation in CAR-T cells by modulating BATF and EGR1.","date":"2024","source":"Biomarker research","url":"https://pubmed.ncbi.nlm.nih.gov/39407311","citation_count":10,"is_preprint":false},{"pmid":"28242623","id":"PMC_28242623","title":"Type I interferon-enhanced IL-10 expression in human CD4 T cells is regulated by STAT3, STAT2, and BATF transcription factors.","date":"2017","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/28242623","citation_count":10,"is_preprint":false},{"pmid":"29898247","id":"PMC_29898247","title":"BATF regulates the expression of Nfil3, Wnt10a and miR155hg for efficient induction of antibody class switch recombination in mice.","date":"2018","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/29898247","citation_count":9,"is_preprint":false},{"pmid":"27073891","id":"PMC_27073891","title":"Regulation of IgA Class Switch Recombination in Immunoglobulin A Nephropathy: Retinoic Acid Signaling and BATF.","date":"2016","source":"American journal of nephrology","url":"https://pubmed.ncbi.nlm.nih.gov/27073891","citation_count":9,"is_preprint":false},{"pmid":"37712938","id":"PMC_37712938","title":"BATF relieves hepatic steatosis by inhibiting PD1 and promoting energy metabolism.","date":"2023","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/37712938","citation_count":8,"is_preprint":false},{"pmid":"38297190","id":"PMC_38297190","title":"BATF and BATF3 deficiency alters CD8+ effector/exhausted T cells balance in skin transplantation.","date":"2024","source":"Molecular medicine (Cambridge, Mass.)","url":"https://pubmed.ncbi.nlm.nih.gov/38297190","citation_count":8,"is_preprint":false},{"pmid":"27648151","id":"PMC_27648151","title":"BATF inhibition prevent acute allograft rejection after cardiac transplantation.","date":"2016","source":"American journal of translational research","url":"https://pubmed.ncbi.nlm.nih.gov/27648151","citation_count":8,"is_preprint":false},{"pmid":"32749698","id":"PMC_32749698","title":"Roles of BATF/JUN/IRF4 complex in tacrolimus mediated immunosuppression on Tfh cells in acute rejection after liver transplantation.","date":"2020","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/32749698","citation_count":8,"is_preprint":false},{"pmid":"38862971","id":"PMC_38862971","title":"BATF promotes tumor progression and association with FDG PET-derived parameters in colorectal cancer.","date":"2024","source":"Journal of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/38862971","citation_count":7,"is_preprint":false},{"pmid":"38477642","id":"PMC_38477642","title":"BATF promotes extramedullary infiltration through TGF-β1/Smad/MMPs axis in acute myeloid leukemia.","date":"2024","source":"Molecular carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/38477642","citation_count":6,"is_preprint":false},{"pmid":"35730016","id":"PMC_35730016","title":"Long Noncoding RNA BCYRN1 Recruits BATF to Promote TM4SF1 Upregulation and Enhance HCC Cell Proliferation and Invasion.","date":"2022","source":"Disease markers","url":"https://pubmed.ncbi.nlm.nih.gov/35730016","citation_count":6,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":48561,"output_tokens":13849,"usd":0.176709,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":25833,"output_tokens":5956,"usd":0.139033,"stage2_stop_reason":"end_turn"},"total_usd":0.315742,"stage1_batch_id":"msgbatch_0179Z2pxRYBsXi2xADneafRw","stage2_batch_id":"msgbatch_01LaY9ZaVdgjWArcZo9eqQE5","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1995,\n      \"finding\": \"B-ATF (BATF) is a nuclear bZIP protein that heterodimerizes with JUN family members (JunB, c-Jun, JunD) but not efficiently with c-Fos, and the B-ATF/c-Jun heterodimer binds AP-1 consensus DNA (TRE sites), establishing BATF as a tissue-specific modulator of AP-1 transcription.\",\n      \"method\": \"Yeast two-hybrid library screen, GST pulldown with in vitro translated proteins, EMSA\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple orthogonal in vitro binding assays (Y2H, GST pulldown, EMSA) in the founding paper; replicated in subsequent studies\",\n      \"pmids\": [\"8570175\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"B-ATF physically associates with IFP 35, a leucine zipper protein translocated to the nucleus after interferon treatment, forming B-ATF:IFP 35 heterodimers as an interferon-inducible event.\",\n      \"method\": \"Co-immunoprecipitation, in vitro binding assay\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, single co-IP/pulldown approach without functional mutagenesis\",\n      \"pmids\": [\"8954125\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"SFA-2 (BATF) does not homodimerize efficiently but forms heterodimers preferentially with c-Jun; the SFA-2/c-Jun heterodimer binds preferentially to AP-1 (TRE) and CRE sites.\",\n      \"method\": \"In vitro dimerization assay, EMSA\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — in vitro biochemical assays, single lab, consistent with PMID 8570175\",\n      \"pmids\": [\"8630063\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"B-ATF lacks a conventional transcriptional activation domain; Jun/B-ATF dimers bind TRE sites with a bias over CRE sites; B-ATF inhibits AP-1-mediated transcription in a dose-dependent manner by forming transcriptionally inert Jun/B-ATF heterodimers that compete with Fos for Jun; stable expression of B-ATF blocks focus formation by H-Ras and v-Fos oncoproteins.\",\n      \"method\": \"GAL4 chimeric reporter assay, EMSA, transient transfection reporter assay, focus-formation assay in C3H10T1/2 cells\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — multiple orthogonal functional assays (reporter, EMSA, transformation) in single lab establishing dominant-negative AP-1 mechanism\",\n      \"pmids\": [\"10777209\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Murine BATF/Jun heterodimers bind AP-1 consensus DNA and are transcriptionally inert; overexpression of BATF in thymic T cells reduces AP-1 transactivation in vivo, demonstrating BATF is a negative regulator of AP-1 activity in the thymus.\",\n      \"method\": \"In situ hybridization, AP-1 luciferase reporter transgenic mouse cross, transgenic overexpression\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo reporter assay in transgenic mice with functional readout, single lab\",\n      \"pmids\": [\"11466704\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"BATF expression is induced as an early transcriptional response to IL-6/LIF stimulation and Stat3 activation in M1 myeloid leukemia cells; BATF forms complexes with c-Jun in these cells; forced BATF expression reduces cell growth rate.\",\n      \"method\": \"Representational difference analysis, immunoblot, co-immunoprecipitation, forced expression growth assay\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal co-IP plus functional growth assay, single lab\",\n      \"pmids\": [\"12444555\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"BATF is phosphorylated in vivo on multiple serine and threonine residues and at least one tyrosine residue; phosphorylation of serine-43 within the DNA-binding domain (modeled by S43D mutation) converts BATF from a DNA-binding to a non-DNA-binding inhibitor of AP-1 activity while retaining dimerization with Jun and nuclear localization.\",\n      \"method\": \"In vivo phosphorylation labeling, reverse-polarity PAGE, site-directed mutagenesis (S43D), EMSA, nuclear localization assay, AP-1 reporter assay\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — reconstitution with mutagenesis plus multiple functional assays in single rigorous study\",\n      \"pmids\": [\"12809553\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"EBNA2 and activated Notch up-regulate BATF expression in B cells within 24 h of EBV infection; BATF negatively impacts BZLF1 reporter expression and reduces the frequency of EBV lytic replication in latently infected cells.\",\n      \"method\": \"Differential gene expression analysis, reporter assay, viral replication frequency assay\",\n      \"journal\": \"Journal of virology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reporter assay and lytic replication functional readout, single lab\",\n      \"pmids\": [\"12719594\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Transgenic overexpression of BATF in T cells causes a severe deficiency of NKT cells, demonstrating that precise control of AP-1 activity mediated by BATF is critical for NKT cell development.\",\n      \"method\": \"Transgenic mouse model, flow cytometry, in vivo cytokine production assay\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — transgenic loss-of-function phenotype with defined cellular readout, single lab\",\n      \"pmids\": [\"12594265\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"BATF is required for TH17 cell differentiation; Batf−/− T cells fail to induce RORγt and IL-21, are resistant to experimental autoimmune encephalomyelitis, and BATF binds conserved intergenic elements in the Il17a-Il17f locus and the Il17, Il21, and Il22 promoters after TH17 differentiation.\",\n      \"method\": \"Batf knockout mouse, ChIP, EMSA, retroviral overexpression, EAE model\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — KO mouse with defined phenotype, ChIP showing direct locus binding, replicated across multiple studies\",\n      \"pmids\": [\"19578362\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"BATF is required for Th17, Th2, and Tfh cell differentiation and for B-cell class-switch recombination; adoptive transfer experiments established that the B-cell CSR defect is driven by T-cell intrinsic BATF loss, while B-cell-intrinsic BATF is also required for in vitro CSR.\",\n      \"method\": \"Batf knockout mouse (BatfΔZ/ΔZ), adoptive transfer, in vitro B-cell stimulation, Ig class-switch analysis\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple cellular assays plus adoptive transfer epistasis, replicated across labs\",\n      \"pmids\": [\"20421391\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"PD-1 ligation upregulates BATF in exhausted CD8+ T cells; enforced BATF expression is sufficient to impair T cell proliferation and cytokine secretion; BATF knockdown reduces PD-1-mediated inhibition and rescues HIV-specific T cell function.\",\n      \"method\": \"Gene expression profiling of HIV-specific CD8+ T cells, lentiviral BATF overexpression, siRNA knockdown, T cell functional assays\",\n      \"journal\": \"Nature medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal gain- and loss-of-function with defined functional readouts in human and mouse systems\",\n      \"pmids\": [\"20890291\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"BATF directly controls expression of Bcl-6 and c-Maf in T cells (required for Tfh development), and AID and germline IH-CH transcripts in B cells (required for CSR); coexpression of Bcl-6 and c-Maf restores Tfh activity in Batf−/− T cells.\",\n      \"method\": \"Batf knockout mouse, ChIP, in vivo complementation/rescue experiments, adoptive transfer\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — ChIP demonstrating direct binding plus genetic rescue experiments, multiple cell types\",\n      \"pmids\": [\"21572431\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"BATF promotes effector CD8+ T-cell differentiation by inhibiting Sirt1 expression (together with c-Jun), resulting in increased histone acetylation of the T-bet locus and elevated cellular NAD+/ATP levels that support effector differentiation and survival.\",\n      \"method\": \"BATF-deficient mouse, ChIP for histone acetylation, NAD+/ATP measurement, transcriptional reporter assay\",\n      \"journal\": \"Proceedings of the National Academy of Sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP plus metabolic assays, single lab, mechanistic pathway placement\",\n      \"pmids\": [\"21873234\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"BATF induction downstream of Stat3 signaling in M1 myeloid leukemia cells is required for growth arrest and terminal macrophage differentiation; Stat3 binds the Batf promoter to drive its transcription; Batf in turn represses c-Myb to enable differentiation.\",\n      \"method\": \"RNA interference knockdown, rescue expression, ChIP for Stat3 at Batf promoter, gene expression analysis\",\n      \"journal\": \"Molecular cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP plus RNAi/rescue functional assays, single lab\",\n      \"pmids\": [\"21296860\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"In CD4+ T cells, BATF-JUN complexes cooperate with IRF4 to bind AP1-IRF composite elements (AICEs; 5'-TGAnTCA/GAAA-3'); BATF binding is diminished in Irf4−/− T cells and IRF4 binding is diminished in Batf−/− T cells, demonstrating functional co-dependence; BATF-JUN-IRF4 complexes cooperatively promote Il10 transcription.\",\n      \"method\": \"ChIP-seq, EMSA, reporter assay, Irf4 and Batf KO T cells\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — ChIP-seq plus EMSA plus reciprocal KO validation; independently replicated\",\n      \"pmids\": [\"22992523\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"BATF (and BATF2) can compensate for BATF3 in CD8α+ dendritic cell development during infection; compensation is based on the shared capacity of BATF leucine zipper domains to interact with IRF4 and IRF8, mediating cooperative gene activation; reciprocal compensation between BATF and BATF3 also occurs in T cells for IL-10 and CTLA4 expression.\",\n      \"method\": \"Batf3 KO mouse, cytokine-driven rescue experiments, leucine zipper domain interaction studies, gene expression analysis\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis in vivo plus domain-based interaction mapping; independently replicated\",\n      \"pmids\": [\"22992524\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"BATF is required for Th9 cell differentiation and IL-9 expression in both human and mouse T cells; BATF is enriched in Th9 cells and regulates a Th9-specific transcriptional network.\",\n      \"method\": \"Microarray, BATF KO mouse, BATF overexpression, allergic inflammation model\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — KO and gain-of-function in both mouse and human, replicated in subsequent studies\",\n      \"pmids\": [\"24216482\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"BATF is required for normal expression of gut-homing receptors CCR9 and α4β7 on T helper cells in response to retinoic acid; BATF-deficient T cells show defective RARα binding and histone acetylation at the regulatory regions of the CCR9 and Itg-α4 genes.\",\n      \"method\": \"BATF KO mouse, ChIP for RARα and histone acetylation, flow cytometry, intestinal T cell functional assays\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP demonstrating direct epigenetic mechanism plus cellular phenotype, single lab\",\n      \"pmids\": [\"23460729\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Egr-2 interacts physically with BATF in CD4 T cells and suppresses its interaction with DNA sequences from the IL-17 promoter, thereby inhibiting Th17 differentiation; Egr-2 control of IL-17 is dependent on BATF inhibition without affecting STAT3 or RORγt.\",\n      \"method\": \"Co-immunoprecipitation, EMSA/DNA binding competition assay, Egr-2 KO mouse, Th17 differentiation assay\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP plus DNA binding assay plus KO phenotype, single lab\",\n      \"pmids\": [\"23203924\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"EBNA3C binds strongest to BATF/IRF4 (AICE) and SPI1/IRF4 (EICE) composite sites genome-wide in LCLs; EBNA3C co-immunoprecipitates with Sin3A and is tethered to DNA through BATF-containing complexes; EBNA3C/Sin3A at promoters correlates with transcription downregulation including repression of p14ARF.\",\n      \"method\": \"ChIP-seq, co-immunoprecipitation, conditional EBNA3C inactivation\",\n      \"journal\": \"Proceedings of the National Academy of Sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP-seq plus co-IP establishing BATF as tethering platform for EBNA3C, single study\",\n      \"pmids\": [\"24344258\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"BATF is essential for early effector CD8+ T cell differentiation; BATF-deficient CD8+ T cells show proliferative and metabolic catastrophe early after antigen encounter; BATF together with IRF4 and Jun proteins binds regulatory regions and promotes early expression of T-bet and Blimp-1 while paradoxically repressing IFN-γ and granzyme B genes.\",\n      \"method\": \"Batf KO mouse, ChIP-seq, genome-wide transcriptional profiling, adoptive transfer\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — ChIP-seq plus KO with defined early and late phenotypic readouts; replicated across labs\",\n      \"pmids\": [\"24584090\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"EBNA3A is tethered to DNA through BATF-containing protein complexes; ChIP-re-ChIP confirmed complexes of EBNA3A on DNA together with BATF; EBNA3A coincidence with BATF-IRF4 or RUNX3 is associated with stronger EBNA3A ChIP-seq signals.\",\n      \"method\": \"ChIP-seq, ChIP-re-ChIP\",\n      \"journal\": \"Proceedings of the National Academy of Sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP-re-ChIP establishing protein complex on chromatin, single lab\",\n      \"pmids\": [\"25540416\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"BATF is required for sustained CD8+ T cell effector function during LCMV infection; absence of BATF results in reduced CD8+ T cell responses and promotes viral persistence; IRF4 and BATF cooperate as necessary partners for antiviral cytotoxic T cell immunity.\",\n      \"method\": \"Irf4 KO and Batf KO mouse, LCMV infection model, T cell proliferation and effector function assays\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — two independent KO lines with defined phenotypic readouts, single lab\",\n      \"pmids\": [\"24531538\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"BATF is required to initiate but not maintain CD8+ T-cell effector differentiation; inducible in vivo RNAi showed BATF is essential for the initial commitment of naive CD8+ T cells to effector development but becomes dispensable by 72 h post-activation.\",\n      \"method\": \"Inducible in vivo RNAi (bone marrow chimera with inducible shRNA), flow cytometry, adoptive transfer\",\n      \"journal\": \"Proceedings of the National Academy of Sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — novel in vivo inducible KD system with precise temporal resolution, single lab but strong mechanistic resolution\",\n      \"pmids\": [\"25548173\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"IL-21 induces and sustains BATF expression in CD8+ T cells during chronic viral infection; BATF cooperates with IRF4 to preserve Blimp-1 expression and sustain CD8+ T cell effector function; BATF overexpression rescues 'unhelped' CD8+ T cells during chronic LCMV infection.\",\n      \"method\": \"Chronic LCMV infection model, conditional BATF KO, BATF overexpression, flow cytometry, gene expression\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gain- and loss-of-function with defined molecular partner (IRF4) and target (Blimp-1), single lab\",\n      \"pmids\": [\"26527008\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"BATF and IRF4 are necessary for VAT-Treg cell differentiation through direct regulation of ST2 and PPARγ expression.\",\n      \"method\": \"BATF and IRF4 conditional KO mice, ChIP, flow cytometry, metabolic phenotyping\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP plus KO phenotype establishing direct target regulation, single lab\",\n      \"pmids\": [\"25599561\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"BATF, in cooperation with IRF4 along with STAT3 and STAT6, directly binds the CNS2 region of the IL-4 locus in Tfh cells to promote IL-4 expression; Batf-to-c-Maf signaling is an important determinant of IL-4 expression in Tfh cells.\",\n      \"method\": \"ChIP, reporter assay, BATF KO mouse, retroviral overexpression, allergic asthma model\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP at specific locus plus reporter assay, single lab\",\n      \"pmids\": [\"26278622\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Bach2 physically associates with BATF and binds regulatory regions of Th2 cytokine gene loci; the Bach2-BATF complex antagonizes recruitment of the BATF-IRF4 complex to AP-1 motifs, suppressing Th2 cytokine production; Bach2 also regulates Batf and Batf3 expression by inhibiting IL-4 production and by directly binding the Batf and Batf3 gene loci.\",\n      \"method\": \"Co-immunoprecipitation, ChIP, cytokine production assays, Bach2 KO mouse\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal co-IP plus ChIP establishing competitive complex formation, multiple orthogonal methods\",\n      \"pmids\": [\"27581382\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"BATF/JUN-B and BATF/C-JUN complexes form in chondrocytes; overexpression of BATF induces upregulation of matrix-degrading enzymes and downregulation of cartilage matrix molecules; ChIP confirmed BATF and JUN binding to promoter regions of catabolic gene candidates; BATF knockout suppresses experimental osteoarthritis.\",\n      \"method\": \"ChIP, adenoviral BATF overexpression, BATF KO mouse, DMM and intra-articular injection OA models\",\n      \"journal\": \"Annals of the rheumatic diseases\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP plus KO and OE with defined phenotype, single lab\",\n      \"pmids\": [\"27147707\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"In Th2 cells, BATF is enriched at the Rad50 hypersensitivity sites (RHS6 and RHS7) of the Th2 locus control region rather than at proximal cytokine promoters; BATF-deficient CD4+ T cells fail to acquire permissive epigenetic modifications at the Th2 locus linked to RHS6/7 function.\",\n      \"method\": \"ChIP-seq, BATF KO mouse, helminth infection model, epigenetic (H3K4me3/H3K27ac) profiling\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP-seq demonstrating novel LCR binding mechanism, single lab\",\n      \"pmids\": [\"27798167\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"IRF1 and BATF are induced early by IL-27 during Tr1 cell differentiation and are required for differentiation and function; both transcription factors influence chromatin accessibility and expression of genes required for Tr1 cell function, with unique pioneering functions.\",\n      \"method\": \"ATAC-seq, ChIP-seq, IRF1 and BATF KO T cells, in vitro and in vivo Tr1 differentiation\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — ATAC-seq plus ChIP-seq plus KO phenotype establishing pioneering function; multiple orthogonal methods\",\n      \"pmids\": [\"28166218\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"The BATF-IRF4 ternary complex shows a spectrum of occupancy at enhancers that correlates with sensitivity of gene expression to TCR signal strength; DNA sequences flanking the AICE motif control the affinity of BATF-IRF4 for direct binding to DNA; ChIP-exo identified a high-affinity AICE2 motif at a human CTLA-4-associated SNP.\",\n      \"method\": \"ChIP-seq, ChIP-exo, graded TCR stimulation, direct binding affinity measurements\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — ChIP-exo plus quantitative binding affinity analysis linking motif sequence to signal-strength-dependent gene expression\",\n      \"pmids\": [\"28346410\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"A Foxp3 A384T missense mutation (IPEX patient-derived) impairs BATF expression in Treg cells by altering Foxp3-DNA binding specificity, broadening it at Batf target sites; repressed BATF expression contributes to tissue-restricted inflammation and impaired Treg competition in non-lymphoid tissues.\",\n      \"method\": \"Knock-in Foxp3 mutant mouse models, ChIP, Treg functional assays\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP plus knock-in genetic model establishing Foxp3-BATF regulatory axis, single lab\",\n      \"pmids\": [\"28778586\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"BATF, IRF4, and IRF8 are recruited to and bind AP1-IRF composite elements (AICEs) in the il12a, ebi3, and il10 loci in activated B cells (Bregs), driving IL-35 and IL-10 production.\",\n      \"method\": \"EMSA, ChIP assay on activated B cells\",\n      \"journal\": \"Journal of leukocyte biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — EMSA plus ChIP demonstrating direct locus binding, single lab\",\n      \"pmids\": [\"30117603\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"BATF quantitative DNA binding preferences (as BATF-JUNB heterodimer and BATF-JUNB-IRF4/8 heterotrimer) were determined in vitro; without IRF, all three BATF family heterodimers show similar TRE/CRE preferences; IRF4/8 binding adjacent to BATF sites increases affinity substantially through protein-protein interactions and alters CRE vs TRE preference.\",\n      \"method\": \"Spec-seq (in vitro quantitative binding to large sequence collections), recombinant proteins\",\n      \"journal\": \"BMC molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution with quantitative binding measurements, systematic sequence analysis\",\n      \"pmids\": [\"29587652\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"BATF controls formation of colon-infiltrating IL-7R+GM-CSF+ donor T effector memory cells that are sufficient to promote intestinal GVHD; this T cell subset's formation is dependent on T cell-intrinsic BATF expression.\",\n      \"method\": \"MHC-mismatched and miHA-mismatched GVHD mouse models, BATF KO adoptive transfer, flow cytometry\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — cell-type-specific KO with defined cellular phenotype in two GVHD models, single lab\",\n      \"pmids\": [\"29376889\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Batf pioneers chromatin accessibility in developing effector T cells and controls developmentally regulated recruitment of the architectural factor Ctcf to promote chromatin looping associated with lineage-specific gene transcription; the Ctcf recruitment by Batf is largely dependent on Ets1 and does not require Batf-Irf complexes at AICE sites.\",\n      \"method\": \"ChIP-seq for Batf, Ctcf, and Ets1; ATAC-seq; Hi-C/chromatin interaction assays; Batf KO and Ets1 KO T cells\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — multiple genome-wide epigenomic methods plus KO establishing pioneer and architectural role, single lab\",\n      \"pmids\": [\"31665634\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"BATF function in Th subsets is specified by its interacting partners: JunB and c-Jun (but not JunD) cooperate with BATF to promote IL-9 in Th9 cells; low Jun expression in Th17 cells limits BATF-driven IL-9; Bach2 cooperates with BATF to induce IL-9 by directly binding the Il9 gene.\",\n      \"method\": \"Primary mouse T cell culture, ectopic expression, ChIP, cytokine production assays\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP plus overexpression in primary T cells establishing partner-dependent specificity, single lab\",\n      \"pmids\": [\"31451674\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"BATF is required for the molecular tissue program of nonlymphoid tissue Treg cell precursors residing in secondary lymphoid organs; global chromatin profiling showed BATF drives stepwise acquisition of chromatin accessibility toward the tissue Treg phenotype.\",\n      \"method\": \"scRNA-seq, ATAC-seq, BATF KO validation in precursor populations, Nfil3 reporter mice\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — ATAC-seq plus scRNA-seq plus functional KO validation; multiple orthogonal methods in single study\",\n      \"pmids\": [\"31924477\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"STAT5 is the earliest factor binding and remodeling the Il9 locus in Th9 cells, and this is required for BATF binding at the Il9 locus; STAT5 mediates accessibility for BATF at the Il9 locus in multiple Th lineages, allowing acquisition of an IL-9-secreting phenotype; STAT5 and BATF together can convert Th17 cells to IL-9 producers.\",\n      \"method\": \"ChIP-seq, ATAC-seq, STAT5 and BATF KO T cells, retroviral overexpression, allergy and tumor models\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — ChIP-seq plus ATAC-seq plus KO establishing ordered pioneer mechanism, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"32985505\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"BATF is selectively required for the development and function of IL-25-responsive migratory iILC2s (IL-17RBhigh, KLRG1high) during helminth infection; BATF directly binds cis-regulatory elements of wound healing genes in ILC2s and maintains their chromatin accessibility; BATF also supports the IL-33-ST2 feed-forward loop sustaining ILC2 identity.\",\n      \"method\": \"BATF KO mouse, Nippostrongylus infection, scRNA-seq, ChIP-seq, flow cytometry\",\n      \"journal\": \"Science immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP-seq plus KO with defined cellular phenotype, single lab\",\n      \"pmids\": [\"31924686\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"BATF is induced during ILC development at the α-lymphoid progenitor stage in response to IL-7; BATF binds and activates transcription of the Nfil3 gene to promote ILC hematopoiesis; BATF deficiency causes ILC lymphopenia affecting ILC1, ILC2, ILC3, and NK cells.\",\n      \"method\": \"BATF KO mouse, ChIP, IL-7 stimulation assays, bone marrow progenitor analysis, enteric infection model\",\n      \"journal\": \"Science immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP at Nfil3 locus plus KO phenotype, single lab\",\n      \"pmids\": [\"33277375\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"BATF and IRF4 cooperate to counter T cell exhaustion in tumor-infiltrating CAR T cells; BATF overexpression in CAR T cells promotes survival, expansion, effector cytokine production, decreased TOX/inhibitory receptor expression, and generation of long-lived memory T cells; these responses require BATF-IRF4 protein-protein interaction, as a BATF variant unable to interact with IRF4 failed to mediate these effects.\",\n      \"method\": \"CAR T cell tumor models (mouse), BATF overexpression, BATF-IRF4 interaction-deficient BATF mutant, flow cytometry, tumor growth assays\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — domain mutagenesis establishing interaction requirement plus in vivo functional readout, multiple orthogonal assays\",\n      \"pmids\": [\"34282330\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"BATF maintains a permissive chromatin structure allowing transition from TCF-1+ progenitor CD8+ T cells to CX3CR1+ cytotoxic effector cells during chronic viral infection; BATF directly binds regulatory regions near Tbx21 and Klf2 to modulate their enhancer accessibility.\",\n      \"method\": \"Genetic deletion of Batf in chronic LCMV model, ATAC-seq, ChIP-seq, gene regulatory network analysis\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — ATAC-seq plus ChIP-seq plus KO establishing direct chromatin mechanism, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"34282329\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"BATF promotes ILC2 proliferation and function and restricts ILC2-to-ILC3 plasticity during influenza infection; BATF directly binds cis-regulatory elements of wound healing genes and maintains their chromatin accessibility; BATF plays a role in an IL-33-ST2 feed-forward loop supporting ILC2 identity.\",\n      \"method\": \"BATF KO mouse, influenza infection model, scRNA-seq, ChIP-seq, ATAC-seq\",\n      \"journal\": \"Science immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — ChIP-seq plus ATAC-seq plus KO with defined plasticity phenotype, single lab multiple orthogonal methods\",\n      \"pmids\": [\"35030033\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"BATF directly binds and up-regulates a subset of exhaustion-related genes in human CAR T cells; knocking out BATF shifts the CAR T cell population toward a more central memory subset and enhances antitumor activity against solid tumors.\",\n      \"method\": \"Candidate gene screen, BATF KO (CRISPR) in human CAR T cells, ChIP, tumor xenograft models, transcriptomic analysis\",\n      \"journal\": \"Cancer cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP establishing direct binding plus CRISPR KO with in vivo functional readout, single lab\",\n      \"pmids\": [\"36240777\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"BATF mediates chromatin organization at several levels in CD8+ T cells including regulatory region accessibility, enhancer-gene interactions, and TF co-binding; Batf and Irf4 together (not Batf alone) are sufficient to increase accessibility and transcription at key T cell function loci in fibroblasts; addition of Runx3 and T-bet further fine-tunes changes and is essential for establishing T cell-characteristic chromatin loops.\",\n      \"method\": \"ATAC-seq, ChIP-seq, Hi-C chromatin interaction mapping, ectopic TF overexpression in fibroblasts, Batf KO CD8+ T cells\",\n      \"journal\": \"Science immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — reconstitution in fibroblasts plus genome-wide epigenomic profiling establishing cooperative pioneer mechanism; multiple orthogonal methods\",\n      \"pmids\": [\"35179948\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"BATF is a key regulator of Treg cell differentiation and activation in the tumor microenvironment, controlling activation-associated gene expression epigenetically; BATF deficiency in Treg cells inhibits tumor growth in mouse models.\",\n      \"method\": \"scRNA-seq, scATAC-seq, BATF KO in Treg cells (mouse), CUT&Tag, tumor growth assay\",\n      \"journal\": \"Science immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — scATAC plus KO phenotype in vivo, single lab\",\n      \"pmids\": [\"36206353\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"BATF is required for maintenance of ILC3 lineage identity in the gut; BATF directly binds cis-regulatory elements of type 1 effector genes and restrains their chromatin accessibility; BATF also promotes chromatin accessibility of MHCII antigen presentation genes to facilitate transition to MHCII+ ILC3s.\",\n      \"method\": \"ILC3-specific BATF KO mouse, ATAC-seq, ChIP-seq, antibiotic treatment, IFN-γ blockade epistasis experiments\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — ATAC-seq plus ChIP-seq plus conditional KO with multiple mechanistic epistasis experiments, single lab\",\n      \"pmids\": [\"36048018\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"FOSL1, FOSL2, and BATF share occupancy over regulatory regions of Th17 lineage commitment genes and share protein-interacting partners in human T cells; these AP-1 factors functionally interact during early human Th17 differentiation with BATF promoting the Th17 lineage.\",\n      \"method\": \"ChIP-seq, co-immunoprecipitation, siRNA knockdown in human T cells, genome-wide binding analysis\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP-seq plus co-IP in human primary cells, single lab\",\n      \"pmids\": [\"35511484\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Batf stabilizes Th17 cell identity by restraining IL-2 expression and IL-2-induced Stat5 activation, which in turn limits Stat5-dependent recruitment of Ets1-Runx1 factors to Th1- and Treg-specific gene loci; Batf thus acts indirectly to inhibit a competing Stat5-Ets1-Runx1 enhanceosome.\",\n      \"method\": \"Batf KO T cells, ChIP-seq for Stat5/Ets1/Runx1, IL-2 manipulation, Th17 stability assays\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP-seq plus genetic manipulation establishing indirect mechanism through competing enhanceosome, multiple orthogonal methods in single study\",\n      \"pmids\": [\"36917143\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"BATF is a central component of a gene regulatory network governing TNFR+ intratumoral Treg cells; CRISPR-mediated BATF KO in human activated Tregs limits excessive activation and promotes survival of activated Tregs in vitro.\",\n      \"method\": \"scRNA-seq, CRISPR-Cas9 KO in human Tregs, bulk RNA-seq, immunophenotyping, in vitro functional suppression assay\",\n      \"journal\": \"Science immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — CRISPR KO plus transcriptomics in human primary cells, single lab\",\n      \"pmids\": [\"37713508\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"BATF represses BIM (Bcl2l11) expression in anergic T cells to sustain peripheral tolerance; BATF-deficient tolerized CD4+ T cells resist anergy induction and undergo clonal deletion due to BIM upregulation; simultaneous Batf and Bcl2l11 double knockdown restores anergic T cell survival.\",\n      \"method\": \"In vivo antigen-driven anergy model, BATF KO and Bcl2l11 KO mouse, double-knockdown epistasis, ChIP/ATAC-seq\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — double-KD genetic epistasis plus epigenomic data establishing direct repression of BIM, single lab but rigorous experimental design\",\n      \"pmids\": [\"37862030\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"BATF is required for Treg stability and FOXP3 expression; BATF regulates demethylation and chromatin accessibility of the CNS2 region of the Foxp3 locus; Treg-specific BATF KO causes multiorgan autoimmune pathology.\",\n      \"method\": \"Treg-specific BATF KO mouse, ATAC-seq, bisulfite sequencing (CNS2 methylation), ChIP-seq, flow cytometry\",\n      \"journal\": \"Advanced science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — multiple epigenomic methods plus conditional KO with defined phenotype and locus-specific mechanism, single lab\",\n      \"pmids\": [\"37587835\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Tox-induced IL-10 expression in T cells is dependent on BATF; Tox and BATF co-bind regulatory regions of the IL-10 gene along with IRF4 and JunB; cosilencing of BATF abolishes Tox-mediated IL-10 induction but not PD-1 upregulation.\",\n      \"method\": \"ChIP, co-occupancy analysis, BATF siRNA knockdown, Tox overexpression in multiple Th subsets\",\n      \"journal\": \"Frontiers in immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP co-occupancy plus siRNA epistasis establishing BATF as downstream mediator, single lab\",\n      \"pmids\": [\"38054003\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"METTL3 stabilizes BATF mRNA through m6A modification read by IGF2BP2, promoting BATF expression in inflammatory microglia; elevated BATF directly binds promoters of inflammatory cytokine and chemokine genes (including CXCL2) and drives TNF-dependent neurotoxicity; this METTL3-m6A-BATF axis promotes neuroinflammation after TBI.\",\n      \"method\": \"MeRIP-seq, CUT&Tag sequencing, METTL3 conditional KO in microglia, BATF ChIP, in vitro and in vivo TBI/stroke models\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — MeRIP-seq plus CUT&Tag plus conditional KO with mechanistic pathway (m6A-IGF2BP2-BATF) established; multiple orthogonal methods\",\n      \"pmids\": [\"38902548\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"BATF is directly regulated by SMAD2/3 downstream of TGF-β/integrin signaling in NK cells; BATF in turn binds key NK cell exhaustion genes (HAVCR2, LAG3, TIGIT, CTLA4); BATF deletion enhances NK cell function against AML in vitro and in vivo.\",\n      \"method\": \"TGF-β/SMAD pathway inhibition, BATF KO in NK cells, ChIP-seq for BATF at exhaustion gene loci, in vitro and in vivo AML models\",\n      \"journal\": \"Science translational medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP-seq plus KO with in vivo functional readout establishing upstream SMAD2/3 regulation and downstream binding targets, single lab multiple methods\",\n      \"pmids\": [\"39259809\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"BATF directly binds the TGF-β1 promoter in AML cells, transcriptionally enhancing TGF-β1 expression and activating the TGF-β1/Smad2-3/MMP2/9 axis to promote AML cell migration and invasion.\",\n      \"method\": \"ChIP assay, luciferase reporter assay, siRNA knockdown and overexpression in AML cells, in vitro migration/invasion assays, in vivo AML model\",\n      \"journal\": \"Molecular carcinogenesis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP plus reporter assay establishing direct promoter binding, functional KD/OE with defined pathway, single lab\",\n      \"pmids\": [\"38477642\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"BATF directly binds the TGF-β1 promoter in breast cancer cells (confirmed by ChIP and dual luciferase reporter assay), increasing TGF-β1 mRNA and protein levels and promoting EMT; TGF-β1 knockdown reduces migration of BATF-overexpressing cells.\",\n      \"method\": \"Dual luciferase reporter assay, ChIP, siRNA knockdown, BATF overexpression in breast cancer cell lines\",\n      \"journal\": \"Aging\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP plus reporter assay confirming direct binding, functional epistasis, single lab\",\n      \"pmids\": [\"34096887\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"BATF directly binds the GBP-5 promoter and transcriptionally activates GBP-5 expression, which promotes NLRP3 inflammasome activation and hepatocyte death in sepsis-associated liver injury.\",\n      \"method\": \"ChIP, luciferase reporter assay, BATF overexpression, NLRP3 inflammasome activation assay, LPS-induced SALI mouse model\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP plus reporter assay establishing direct transcriptional activation, single lab\",\n      \"pmids\": [\"34042221\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"BATF regulates B cell class-switch recombination by positively regulating Nfil3 and miR155hg, and negatively regulating Wnt10a; inducible BATF deletion demonstrated these are early regulatory targets upstream of germline transcript activation and Aicda induction.\",\n      \"method\": \"Inducible BATF deletion mouse model, ChIP, gene expression analysis, in vitro CSR assay\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP plus inducible KO establishing ordered regulatory network in B cells, single lab\",\n      \"pmids\": [\"29898247\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"BATF is a nuclear bZIP transcription factor that heterodimerizes with JUN family members to bind AP-1/TRE sites and lacks an intrinsic transactivation domain; it gains positive transcriptional activity by cooperating with IRF4 or IRF8 through BATF-JUN-IRF heterotrimer formation at AP1-IRF composite elements (AICEs), a partnership required for its essential roles as a pioneer/architectural factor that remodels chromatin and drives differentiation programs in TH17, TH2, TH9, Tfh, Tr1, Treg, effector and memory CD8+ T cells, ILC subsets, and B cells; phosphorylation of serine-43 in its DNA-binding domain converts BATF from a DNA-binding to a non-DNA-binding AP-1 inhibitor; upstream, BATF expression is induced by signals including STAT3 (via IL-6), IL-21, IL-7, TCR activation, PD-1, and SMAD2/3 (TGF-β), and is post-transcriptionally stabilized by METTL3-m6A-IGF2BP2; downstream, BATF directly binds cis-regulatory elements genome-wide, recruits Ctcf via Ets1 to organize chromatin loops, represses competing lineage programs (e.g., Stat5-Ets1-Runx1 in Th17 stability, BIM in anergic T cells), and transcriptionally activates target genes including Il17, Il21, Il22, Bcl6, c-Maf, AID, Nfil3, T-bet, Blimp-1, and TGF-β1 depending on cellular context.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"BATF is a nuclear bZIP transcription factor that heterodimerizes with JUN family members (JunB, c-Jun, JunD) to bind AP-1/TRE elements and serves as a master architectural regulator of lymphocyte differentiation programs [#0, #9]. Because it lacks a conventional transactivation domain, BATF/JUN dimers are transcriptionally inert and originally function as dominant-negative competitors of Fos for Jun, inhibiting AP-1 activity in a dose-dependent manner [#3, #4]; phosphorylation of serine-43 within its DNA-binding domain further converts BATF into a non-DNA-binding AP-1 inhibitor while preserving dimerization and nuclear localization [#6]. BATF gains positive, lineage-specifying transcriptional activity by cooperating with the interferon regulatory factors IRF4 and IRF8 to form BATF-JUN-IRF heterotrimers that bind AP1-IRF composite elements (AICEs); BATF and IRF4 are reciprocally co-dependent for genomic occupancy, and the sequence flanking the AICE motif tunes complex affinity and sensitivity to TCR signal strength [#15, #16, #32, #35]. Through this partnership BATF acts as a pioneer/architectural factor that opens chromatin, establishes lineage-specific enhancer accessibility, and—via Ets1-dependent recruitment of CTCF—organizes chromatin loops underlying effector gene transcription [#31, #37, #47]. These activities make BATF essential for differentiation of TH17, TH2, TH9, Tfh, Tr1, and tissue/tumor Treg cells, effector and memory CD8+ T cells, ILC subsets, NK cells, and for B-cell class-switch recombination, where it directly activates programs including Il17/Il21/Il22, Bcl6 and c-Maf, T-bet and Blimp-1, AID and Nfil3 [#9, #10, #12, #17, #21, #42, #49, #61]. BATF also enforces regulatory and tolerance programs—stabilizing Th17 identity by restraining a competing Stat5-Ets1-Runx1 enhanceosome, sustaining anergic T cell survival by repressing BIM, and maintaining Foxp3/Treg stability via CNS2 demethylation—and is co-opted in T cell exhaustion downstream of PD-1, where its IRF4 partnership is required to either drive or, when deleted, relieve exhaustion in CAR T cells [#11, #43, #46, #51, #53, #54]. Upstream, BATF expression is induced by STAT3, IL-21, IL-7, TGF-\\u03b2/SMAD2/3, and TCR/PD-1 signals and is post-transcriptionally stabilized by METTL3-m6A-IGF2BP2 [#5, #25, #42, #56, #57].\",\n  \"teleology\": [\n    {\n      \"year\": 1995,\n      \"claim\": \"Established BATF's foundational biochemical identity, answering whether this bZIP protein acts alone or through dimerization to engage AP-1 DNA.\",\n      \"evidence\": \"Yeast two-hybrid, GST pulldown, and EMSA defining JUN-family heterodimerization and TRE binding\",\n      \"pmids\": [\"8570175\", \"8630063\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No cellular function or target genes identified\", \"Transcriptional output of the dimer not yet defined\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Resolved whether BATF activates or represses AP-1 transcription, showing it lacks a transactivation domain and acts as a dominant-negative competitor for Jun.\",\n      \"evidence\": \"GAL4 reporter, EMSA, and focus-formation assays in fibroblasts\",\n      \"pmids\": [\"10777209\", \"11466704\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which BATF later becomes a positive regulator unresolved\", \"No physiological lineage context\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Identified a post-translational switch—serine-43 phosphorylation—that toggles BATF between DNA-binding and non-DNA-binding inhibitory states.\",\n      \"evidence\": \"In vivo phospho-labeling and S43D mutagenesis with EMSA and AP-1 reporter assays\",\n      \"pmids\": [\"12809553\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Kinase responsible for S43 phosphorylation not identified\", \"In vivo physiological role of the switch untested\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Defined BATF's first essential developmental role, showing it is required for TH17 differentiation and binds the Il17/Il21/Il22 loci directly.\",\n      \"evidence\": \"Batf knockout mice, ChIP, EMSA, and EAE autoimmunity model\",\n      \"pmids\": [\"19578362\", \"20421391\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How a transactivation-deficient factor activates target genes unexplained\", \"Cofactors enabling positive output unknown\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Extended BATF's reach to Tfh and B-cell programs and to CD8+ effector differentiation by identifying direct targets Bcl6, c-Maf, AID, and Sirt1-linked T-bet regulation.\",\n      \"evidence\": \"Knockout mice, ChIP, and genetic rescue/complementation experiments across T and B cells\",\n      \"pmids\": [\"21572431\", \"21873234\", \"20890291\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular basis for positive transcription still missing\", \"Direct vs indirect target distinction incomplete\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Solved the central mechanistic puzzle of how a transactivation-deficient factor activates genes, showing BATF-JUN cooperates with IRF4 at AP1-IRF composite elements with reciprocal binding co-dependence.\",\n      \"evidence\": \"ChIP-seq, EMSA, reporter assays, and reciprocal Batf/Irf4 knockout T cells\",\n      \"pmids\": [\"22992523\", \"22992524\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of the heterotrimer not resolved\", \"Determinants of context-specific target selection unknown\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Broadened the lineage program (Th9, gut-homing receptors) and revealed antagonistic partners, showing Egr-2 binds BATF to block its DNA engagement and limit Th17.\",\n      \"evidence\": \"Knockout mice, ChIP for RARα and histone marks, co-IP, and DNA-binding competition assays\",\n      \"pmids\": [\"24216482\", \"23460729\", \"23203924\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Quantitative balance between activating and inhibitory partners undefined\", \"Single-lab co-IP for Egr-2 interaction\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Established BATF as essential specifically for initiation of CD8+ effector differentiation and antiviral cytotoxicity, with precise temporal resolution.\",\n      \"evidence\": \"ChIP-seq, Batf knockout, inducible in vivo RNAi, and LCMV infection models\",\n      \"pmids\": [\"24584090\", \"25548173\", \"24531538\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism for switch from required to dispensable not explained\", \"Paradoxical repression of IFN-γ/granzyme B unresolved\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Mapped BATF-IRF4 partnership into chronic infection and tissue Treg/Tfh programs, defining IL-21-driven induction and direct ST2/PPARγ/IL-4 locus regulation.\",\n      \"evidence\": \"Conditional knockouts, ChIP, reporter assays, and chronic LCMV/allergy models\",\n      \"pmids\": [\"26527008\", \"25599561\", \"26278622\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab studies for several lineage assignments\", \"Quantitative contribution of each partner not separated\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Revealed competitive and locus-control-region mechanisms, showing Bach2 antagonizes BATF-IRF4 recruitment at AP-1 motifs and BATF binds Th2 LCR hypersensitivity sites rather than proximal promoters.\",\n      \"evidence\": \"Reciprocal co-IP, ChIP/ChIP-seq, and Bach2/Batf knockout cytokine assays\",\n      \"pmids\": [\"27581382\", \"27798167\", \"27147707\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry of competing Bach2 vs IRF4 complexes undefined\", \"How LCR binding propagates to promoters unresolved\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Defined BATF as a pioneer factor controlling chromatin accessibility and showed AICE flanking sequence sets affinity and signal-strength sensitivity.\",\n      \"evidence\": \"ATAC-seq, ChIP-seq, ChIP-exo, graded TCR stimulation, and knockout Tr1 cells\",\n      \"pmids\": [\"28166218\", \"28346410\", \"28778586\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct demonstration of nucleosome engagement absent\", \"Recruitment of remodeling machinery not identified\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Quantified BATF dimer/trimer DNA preferences in vitro and extended its regulatory targets and B-cell network, showing IRF4/8 binding adjacent to BATF boosts affinity and shifts CRE/TRE preference.\",\n      \"evidence\": \"Spec-seq with recombinant proteins, EMSA/ChIP in Bregs, and inducible BATF deletion in B cells\",\n      \"pmids\": [\"29587652\", \"30117603\", \"29898247\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vitro preferences not fully mapped to genomic occupancy\", \"Mechanism of Wnt10a repression undefined\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Established BATF's architectural role and partner-specified output, showing it recruits CTCF via Ets1 to organize chromatin loops independently of AICE sites.\",\n      \"evidence\": \"ChIP-seq for Batf/Ctcf/Ets1, ATAC-seq, Hi-C, and Batf/Ets1 knockout T cells; partner-swap overexpression\",\n      \"pmids\": [\"31665634\", \"31451674\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct BATF-Ets1-CTCF biochemical contacts not mapped\", \"Generality of loop organization across lineages untested\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Defined an ordered pioneer hierarchy and expanded BATF to ILC biology, showing STAT5 remodels the Il9 locus to license BATF binding and BATF drives ILC hematopoiesis via Nfil3.\",\n      \"evidence\": \"ChIP-seq, ATAC-seq, scRNA-seq, and knockouts across Th9, tissue Treg, and ILC compartments\",\n      \"pmids\": [\"32985505\", \"31924477\", \"33277375\", \"31924686\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether STAT5 directly hands off chromatin to BATF biochemically unknown\", \"Cross-lineage generality of the ordered mechanism untested\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Connected BATF to exhaustion/memory decisions and therapeutic engineering, showing its IRF4 partnership is required to counter CAR T exhaustion while BATF deletion can enhance memory and antitumor activity.\",\n      \"evidence\": \"CAR T tumor models, IRF4-interaction-deficient BATF mutant, CRISPR knockout, ATAC-seq/ChIP-seq in chronic LCMV and ILC2 models\",\n      \"pmids\": [\"34282330\", \"34282329\", \"36240777\", \"35030033\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Context determining whether BATF promotes vs restrains exhaustion unresolved\", \"Dose/timing dependence of therapeutic effect undefined\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Demonstrated minimal-component sufficiency for chromatin remodeling and tumor Treg/ILC3 control, showing BATF+IRF4 (not BATF alone) open T-cell loci and BATF restrains type-1 effector genes in ILC3s.\",\n      \"evidence\": \"Reconstitution in fibroblasts, ATAC/ChIP-seq, Hi-C, conditional knockouts, and CUT&Tag\",\n      \"pmids\": [\"35179948\", \"36206353\", \"36048018\", \"35511484\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Roles of additional factors (Runx3, T-bet) in establishing loops only partially defined\", \"How BATF both opens and restrains accessibility at different loci unexplained\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Resolved indirect and tolerance mechanisms, showing BATF stabilizes Th17 identity by restraining a competing Stat5-Ets1-Runx1 enhanceosome, sustains anergy by repressing BIM, and maintains Foxp3 stability via CNS2 demethylation.\",\n      \"evidence\": \"ChIP-seq, double-knockdown epistasis, bisulfite sequencing, and conditional knockouts with autoimmunity readouts\",\n      \"pmids\": [\"36917143\", \"37862030\", \"37587835\", \"37713508\", \"38054003\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism linking BATF to CNS2 demethylation machinery unresolved\", \"How BATF achieves gene repression mechanistically incomplete\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Defined upstream regulatory inputs and non-lymphoid roles, showing METTL3-m6A-IGF2BP2 stabilizes BATF mRNA in microglia and SMAD2/3 directly drives BATF in NK cells to control exhaustion gene loci.\",\n      \"evidence\": \"MeRIP-seq, CUT&Tag, conditional METTL3 knockout, ChIP-seq, and AML/TBI in vivo models\",\n      \"pmids\": [\"38902548\", \"39259809\", \"38477642\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Integration of m6A and SMAD inputs with transcriptional induction unresolved\", \"Generality of microglial/NK roles beyond disease models untested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How a single architectural factor switches between opening lineage-specific chromatin and restraining alternative-fate loci, and what dictates its context-dependent activating versus repressive output, remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No high-resolution structure of the BATF-JUN-IRF trimer on nucleosomal DNA\", \"Chromatin-remodeling machinery recruited by BATF not identified\", \"Rules selecting activation vs repression at a given locus undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 3, 9, 15, 21]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [0, 2, 9, 15, 32, 35]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [37, 20, 22]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 6]},\n      {\"term_id\": \"GO:0000228\", \"supporting_discovery_ids\": [9, 15, 37]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [9, 10, 11, 21, 43]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [3, 9, 15, 12]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [31, 37, 47, 54]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [10, 17, 42, 39]}\n    ],\n    \"complexes\": [\n      \"BATF-JUN AP-1 heterodimer\",\n      \"BATF-JUN-IRF4 (AICE) ternary complex\",\n      \"BATF-JUN-IRF8 (AICE) complex\"\n    ],\n    \"partners\": [\n      \"JUN\",\n      \"JUNB\",\n      \"IRF4\",\n      \"IRF8\",\n      \"CTCF\",\n      \"ETS1\",\n      \"BACH2\",\n      \"EGR2\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}